Deprecated: The each() function is deprecated. This message will be suppressed on further calls in /home/zhenxiangba/zhenxiangba.com/public_html/phproxy-improved-master/index.php on line 456
JPH0352479B2 - - Google Patents
[go: Go Back, main page]

JPH0352479B2 - - Google Patents

Info

Publication number
JPH0352479B2
JPH0352479B2 JP58144016A JP14401683A JPH0352479B2 JP H0352479 B2 JPH0352479 B2 JP H0352479B2 JP 58144016 A JP58144016 A JP 58144016A JP 14401683 A JP14401683 A JP 14401683A JP H0352479 B2 JPH0352479 B2 JP H0352479B2
Authority
JP
Japan
Prior art keywords
added
reduced pressure
under reduced
dmf
boc
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP58144016A
Other languages
Japanese (ja)
Other versions
JPS6034996A (en
Inventor
Ko Morita
Shigeo Kuzuki
Toshiharu Noda
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Toyo Jozo KK
Original Assignee
Toyo Jozo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Toyo Jozo KK filed Critical Toyo Jozo KK
Priority to JP58144016A priority Critical patent/JPS6034996A/en
Priority to FR8412303A priority patent/FR2550204B1/en
Priority to US06/637,735 priority patent/US4656250A/en
Priority to DE3428942A priority patent/DE3428942C2/en
Publication of JPS6034996A publication Critical patent/JPS6034996A/en
Publication of JPH0352479B2 publication Critical patent/JPH0352479B2/ja
Granted legal-status Critical Current

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)

Description

【発明の詳細な説明】[Detailed description of the invention]

本発明は、新規なヒト副甲状腺ホルモン(h−
PTH)誘導体に関する。さらに詳しくは、本発
明は、副甲状腺機能低下症治療剤として、または
PTHが関与する治療剤として、あるいは副甲状
腺機能検査のための標識化合物の原料として有用
な〔Nle8,Nle18,Tyr34〕−h−PTH(1−34)
NH2、即ち式 H−S1 er−V2al−S3 er−G4 lu−I5 le−G6 lo−L7 eu−N8
is
A10 so−L11 eu−G12ly−L13 ys14is−L15eu−A16 so−S1
7
er−N18 le
G19 lu−A20 rg−V21 al−G22 lu−T23 rp−L24 eu−A25 rg−L
26 ys−L27 ys
−L28 eu−G29 lo−A30 sp−V31 al−H32is−A33 so−T34 yr
−NH2
……〔) (式中、SerはL−セリン、ValはL−バリン、
GluはL−グルタミン酸、IleはL−イソロイシ
ン、GlnはL−グルタミン、LeuはL−ロイシン、
NleはL−ノルロイシン、HisはL−ヒスチジン、
AsnはL−アスパラギン、Glyはグリシン、Lys
はL−リジン、ArgはL−アルギニン、TrpはL
−トリプトフアン、AsPはL−アスパラギン酸、
TyrはL−チロシンを示す)で表わされるペプチ
ドまたはその塩である。 h−PTHは84個のアミノ酸よりなるペプチド
ホルモンで、その生物学的活性はアミノ酸順位1
−34のN末端フラグメント、即ちh−PTH(1−
34)に有すると報告されている〔Proc.Nat.
Acad.Sci.U.S.A.,68,63−67(1971)〕。しかしな
がら、h−PTHはL−メチオニン(Met)が存
在するため不安定であり、I125で標識するとホル
モン活性が失なわれる〔Recent Prog.Hormone
Res.,18,269〜295(1962)〕。 従来のh−PTHの定量法では、h−PTH活性
を有する部分のみを定量するために、h−PTH
(1−34)を抗原とした特異抗体が調製されるよ
うになつた。しかしながら、h−PTH(1−34)
はL−メチオニン(Met)が存在するため不安定
であり、I125で標識化する際、8位および18位に
存在するMetが酸化されてホルモン活性が失活す
るという欠点があつた。 そこで、PTH活性を有し、PTHの抗体に対し
て免疫活性を有するのみならず、I125で標識化し
てもホルモン活性が安定であり、且つ安定な放射
活性を有するh−PTH誘導体として、8位およ
び18位のMetをL−ノルロイシンに換え、34位の
L−フエニルアラニンをL−チロシンに換えた
〔N8 le,N18 le,T34 yr 34〕−h−PTH(1−34)が見い
出された〔特開昭55−113753号〕。 しかしながら、この〔N8 le,N18 le,T34 yr〕−h−
PTH(1−34)は、その分子内にMetが存在しな
いため、I125で標識しても失活しないが、そのホ
ルモン活性は高々天然型h−PTH(1−34)と同
程度の活性を有するに過ぎなかつた。 本目的化合物〔〕はPTHのリセプターに対
し公知のh−PTH(1−34)および〔N8 le,N18 le
T34 yr〕−h−PTH(1−34)よりも強い親和力を有
し、約1.5〜2倍のh−PTH活性を有するののみ
なならず、PTHの抗体に対しても免疫活性を有
し、I125で標識してもホルモン活性は低下せず、
〔N8 le,N18 yr,T34yr〕−h−PTH(1−34)より約2
倍の放射活性を有しており、長期の保存において
も生物活性が低下しないため、公知のh−PTH
(1−34)、〔N8 le,N18 le,T34 yr〕−h−PTH(1−
34)より極めてて優れた効果を発揮する。このた
め、本目的化合物〔〕は副甲状腺機能低下症治
療剤、PTHが関与する骨の治療剤および副甲状
腺機能検査のための標識化合物の原料として極め
て有用なペプチドである。 本発明のペプチド〔〕は、C末端チロシル基
のカルボキシル基をアミド基に転化し、式〔〕
で示されるアミノ酸順序に個々の保護されたアミ
ノ酸および(または)保護された低級ペプチドを
液相合成法により縮合し、縮合反応の最終段階で
N末端のアミノ基の保護基および側鎖の官能基の
保護基を酸分解により脱離することにより得られ
る。縮合反応自体はペプチド合成のための常法手
段に従つて、保護基の着脱、縮合反応を繰り返す
ことにより行われる。即ち、本ペプチド〔〕の
原料ならびにすべての中間体の製造において使用
される各種保護基はペプチド合成で既知なもの、
従つて加水分解、酸水解、還元、アミノリシスま
たはヒドラジノリシスのような既知手段によつて
容易に脱離することのできる保護基が用いられ
る。このような保護基はペプチド合成化学の分野
の文献ならびに参考書に記載されている。 例えば、アミノ基に使用する保護基としては、
ホルミル基、トリフルオロアセチル基、フタロイ
ル基、p−トルエンスルホニル基、o−ニトロフ
エニルスルフエニル基などのアシル基、ベンジル
オキシカルボニル基、o(またはp)−ブロモベン
ジルオキシカルボニル基、o(またはp)−クロロ
ベンジルオキシカルボニル基、p−ニトロベンジ
ルオキシカルボニル基、p−メトキシベンジルオ
キシカルボニル基などのベンジルオキシカルボニ
ル基、トリクロロエチルオキシカルボニル基、t
−ブチルオキシカルボニル基、t−アミルオキシ
カルボニル基、ジイソプロピルメチルオオキシカ
ルボニル基などの脂肪族オキシカルボニル基、2
−フエニル−イソプロポキシカルボニル基、2−
トリル−イソプロポキシカルボニル基、2−p−
ジフエニル−イソプロポキシカルボニル基などの
アラルキルオキシカルボニル基などがある。また
これらアミノ基をベンゾイルアセトン、アセチル
アセトンなどの1,3−ジケトンと反応させるこ
とによつて得られるエナミンの形成により保護す
ることができる。 カルボキシル基は、アミド形成、ヒドラチド形
成またはエステル化によつて保護される。即ちア
ミド基は、3,4−ジメトキシベンジル基、ビス
−(p−メトキシフエニル)メチル基などによつ
て置換される。ヒドラチド基はベンジルオキシカ
ルボニル基、トリクロロエチルオキシカルボニル
基、トリフルオロアセチル基、t−ブチルオキシ
カルボニル基、トリチル基、2−p−ジフエニル
−イソプロポキシカルボニル基などによつて置換
される。エステル基はメタノール、エタノール、
t−ブタノール、シアノメチルアルコールなどの
アルカノール、ベンジルアルコール、p−ブロモ
ベンジルアルコール、p−クロロベンジルアルコ
ール、2,6−ジクロロベンジルアルコール、p
−メトキシベンジルアルコール、p−ニトロベン
ジルアルコール、ベンズヒドリルアルコール、ベ
ンゾイルメチルアルコール、p−ブロモベンゾイ
ルメチルアルコール、p−クロロベンゾイルメチ
ルアルコールなどのアラルカノール、2,4,6
−トリクロロフエノール、2,4,5−トリクロ
ロフエノール、ペンタクロロフエノール、p−ニ
トロフエノール、2,4−ジニトロフエノールな
どのフエノール、チオフエノール、p−ニトロチ
オフエノールなどのチオフエノールなどによつて
置換される。 前記セリンおよびチロシンの水酸基は、例えば
エステル化またはエーテル化によつて保護するこ
とができる。このエステル化に適する基として
は、例えばアセチル基、ベンゾイル基、ベンジル
オキシカルボニル基、エチルオキシカルボニル基
などである。またエーテル化に適する基として
は、例えばベンジル基、2,6−ジクロロベンジ
ル基、テトラヒドロピラニル基、t−ブチル基で
ある。これらの水酸基の保護には2,2,2−ト
リフルオロ−1−t−ブチルオキシカルボニルア
ミノエチル基、2,2,2−トリフルオロ−1−
ベンジルオキシカルボニルアミノ基も適する。し
かしながら、これらの水酸基を必らずしも保護す
る必要はない。 前記アルギニンのグアニジノ基中のアミノ基を
保護するのに使用する基としては、例えばニトロ
基、トシル基、ベンジルオキシカルボニル基、メ
シチレン−2−スルホニル基などであるが、この
グアニジノ基を必ずしも保護する必要はない。 前記ヒスチジンのイミノ基を保護するのに使用
する基としては、例えばベンジル基、トリチル
基、ベンジルオキシカルボニル基、トシル基、
2,2,2−トリフルオロ−1−t−ブチルオキ
シカボニルアミノエチル基、2,2,2−トリフ
ルオロ−1−−ベンジルオキシカルボニルアミノ
エチル基などであるが、このイミノ基を必ずしも
保護する必要はない。 本発明においては、α−アミノ基の保護にt−
ブチルオキシカルボニル基、t−アミルオキシカ
ルボニル基を用い、側鎖のアミノ基、即ちリジン
のξ−アミノ基の保護にo−クロロベンジルオキ
シカルボニル基を用い、α−カルボキシル基の保
護にベンジルエステル基、エチルエステル基、フ
エナシルエステル基を用い、側鎖のカルボキシル
基、即ちグルタミン酸、アスパラギン酸の側鎖カ
ルボキシル基の保護にベンジルエステル基を用い
セリンの水酸基の保護にベンジル基を用い、チロ
シンの水酸基の保護に2,6−ジクロロベンジル
基を用い、アルギニンのグアニジノ基中のアミノ
基の保護にトシル基またはメシチレン−2−スル
ホニル基を用いるのが好ましい。 本目的化合物〔〕の合成においては、個々の
アミノ酸および(または)低級ペプチドの縮合
は、例えば保護されたα−アミノ基および活性化
末端カルボキシル基をもつアミノ酸またはペプチ
ドと遊離のα−アミノ基および保護された末端カ
ルボキシル基をもつアミノ酸またはペプチドとを
反応させるか、あるいは活性化α−アミノ基おお
よび保護された末端カルボキシル基をもつアミノ
酸またはペプチドと遊離の末端カルボキシル基お
よび保護されたα−アミノ基をもつアミノ酸また
はペプチドを反応させることにより、実施するこ
とができる。 この場合、カルボキシル基は、例えば酸アジ
ド、酸無水物、酸イミダゾリドまたは活性エステ
ル、例えばシアノメチルエステル、チオフエニル
エステル、p−ニトロチオフエニルエステル、p
−ニトロフエニルエステル、2,4−ジニトロフ
エニルエステル、2,4,5−トリクロロフエニ
ルエステル、2,4,6−トリクロロフエニルエ
ステル、ペンタクロロフエニルエステル、N−ヒ
ドロキシコハク酸イミドエステル、N−ヒドロキ
シフタル酸イミドエステルなどに変換することに
よつて活性化することができる。またカルボジイ
ミド、例えばN,N′−ジシクロヘキシル−カル
ボジイミド、N−エチル−N′−3−ジメチルア
ミノプロピル−カルボジイミド、N,N′−カル
ボニル−ジイミダゾールまたはイソオキゾリウム
塩、例えばウツドワード反応剤などの縮合剤を使
用して反応させることによつて活性化することが
できる。 本発明において好ましい縮合方法は、アジド
法、活性エステル法およびカルボジイミド法であ
る。縮合の各段階ではラセミ化が起らない方法ま
たはラセミ化が最少になる方法を用いるのが望ま
しく好ましくはアジド法、活性エステル法、ビユ
ンシユ法〔Z.Naturforsch.,21b,426(1966)〕ま
たはガイガー法〔Chem Ber.,103,788(1970)〕
とりわけ縮合剤としてN−エチル−N′−3−ジ
メチルアミノプロピル−カルボジイミド(WSC)
を用いる変法などを用いるのが適する。 縮合順序は式〔〕で示されるアミノ酸順序で
あれば、如何なる順序からも合成し得るが、C−
末端側から順次アミノ酸および(または)ペプチ
ドを連結させるのが好ましい。 例えば、29〜34番のアミノ酸順序からなるC末
端フラグメントと23〜28番のアミノ酸からなるペ
プチドフラグメントを縮合させるのがよい。この
C−末端フラグメントとヘキサペプチド23−28を
縮合させるにはWSCを用いるガイガー変法によ
つて行うのが適する。得られたC−末端フラグメ
ント23−34の前に18〜22番のアミノ酸順序からな
るペプチドフラグメントを連結させるのである
が、WSCを用いるガイガー変法により行うのが
適する。得られたC−末端フラグメント18−34の
前に順次13〜17番のアミノ酸順序からなるペプチ
ドフラグメント、8〜12番のアミノ酸順序からな
るペプチドフラグメント、1〜7番のアミノ酸順
序からなるペプチドフラグメントを連結させるの
が好ましい。 上記の縮合反応におけるα−アミノ基の保護
基、例えばt−ブチルオキシカルボニル基、t−
アミルオキシカルボニル基はトリフルオロ酢酸で
脱離される。α−カルボキシル基の保護基、例え
ばエチルエステルはこれを希薄な水酸化ナトリウ
ム溶液で分解し、またはヒドラチドあるいはトリ
クロロエトキシカルボニルヒドラチドのような保
護ヒドラチドに変え、フエナシルエステル基は酢
酸中Zn粉末で分解し、またベンジルエステル基
は無水弗化水素分解、水素添加分解によつて分解
し、またはヒドラチドに変えることができる。 こうして保護されたN末端α−アミノ基、ξ−
アミノ基、側鎖カルボキシル基、グアニジノ基お
よび(または)水酸基を有するテトラトリアコン
タペプチドが得られる。これらの保護基は、好ま
しくは酸分解、例えば無水弗化水素またはトリフ
ルオロメタンスルホン酸による方法によつて一段
階で脱離され、式〔〕の目的化合物が得られ
る。 このようにして得られたペプチド〔〕は、ペ
プチドまたは蛋白質を精製する公知の手段によつ
て分離精製することができる。例えば、セフアデ
ツクスG−25、セフアデツクスG−50、セフアデ
ツクスLH−20などのゲル過剤を用いるゲル
過、カルボキシメチルセルロース、イオン交換樹
脂などを用いるカラムクロマトグラフイー、高速
液体クロマトグラフイーなどにより行うことがで
きる。 本発明のペプチド〔〕は、その方法の条件に
より塩基またはその塩の形で得られる塩として
は、無機酸塩、ギ酸、酢酸、プロピオン酸、グリ
コール酸、コハク酸、リンゴ酸、酒石酸、クエン
酸などの有機酸との塩である。 本ペプチド〔〕はある種の無機物質または有
機物質を付加して錯体を形成し得る。この錯体と
は添加した時に生成し、ペプチドに持続作用を与
える未だ構成不明の化合物を意味する。このよう
な物質としては、例えば、カルシウム、マグネシ
ウム、アルミニウム、コバルトまたは亜鉛のよう
な金属から誘導される無機化合物、特にこれら金
属のリン酸塩、ピロリン酸塩またはポリリン酸塩
のような僅かに可溶性の塩ならびに水酸化合物、
あるいはアルカリ金属のポリリン酸塩を挙げるこ
とができる。 さらに本発明のペプチド〔〕は、好ましくは
RIA用標識試薬として利用される。例えば、一定
量の放射活性を有する125I含有リン酸緩衝液(PH
7.1)に本発明のペプチド〔〕およびクロラミ
ンTを加えて撹拌し、次いで重亜硫酸ナトリウム
を加え、さらに少量のヨウ化カリウムおよび血清
アルブミンを加えてクロマトグラフイーを行い、
125Iで標識された分画を集めることにより125Iで
標識された放射活性体が得られる。 次に本発明のペプチド〔〕および125Iで標識
された放射活性体の副甲状腺ホルモン(PTH)
活性について述べる。 <125I標識体の調製> 2mCiの放射活性を有する125I−NaIを含有する
0.5Mリン酸緩衝液(PH7.1)50μlに各々h−PTH
(1−34)、h−PTH(1−34)NH2、〔H8 le
N18 le,T34 yr〕−h−PTH(1−34)および〔N8 le′,
N18 le,T34 yr〕−h−PTH(1−34)NH2の2μg含有
液10μおよびクロラミンT(3.5―mg/ml)含有
液20μlを加えて30秒間撹拌した後、これに重亜硫
酸ナトリウム(4.5mg/ml)含有液50μlを加えて
反応を停止した。これに5%ヒト血清アルブミン
含有0.1N酢酸溶液0.5mlを加えた後、セフアデツ
クスG−10のカラム(1×50cm)にチヤージし、
上記酢酸溶液で溶出して、125Iで標識した各被検
品の含有分画を得た。 <PTH活性測定法> (1) PTHレセプターの調製 SD系雄ラツト(体重200〜250g)を断頭、放
血し、開腹の後、腎を摘出し、その表面皮膜を取
り除き、腎皮質部分を切り取り、氷冷する。以下
の操作はできるだけ低温(0〜4℃)下で行う。
上記の腎皮質部分を0.25Mシユクロースおよび
1mMEDTA含有10mMトリス塩酸塩緩衝液(PH
7.5)(以下A液と称す)中に浸し、テフロンペツ
スルを用いたガラス外套管で腎皮質をその湿重量
(g)の3倍容量(ml)のA液を加えてホモゲナ
イズする。このホモジネートを150Xg、10分間
遠心分離し、その上清をさらに2200Xg、15分間
遠心分離する。上清を捨て、沈澱物の上層の浮濁
色の部分をA液に懸濁し、この懸濁液を2200X
g、155分間遠心分離により洗浄し、再び懸濁し
て容器に分注し、−70℃で凍結して−20℃で保存
する。 (2) PTHとPTHレセプターの反応 被検品を2μg/mlと10μg/mlの濃度になるよ
うにATPMg2mM、MgCl210mM、KCl60mM、
GTP20μM、イソブチルメチルキサンチン1mM、
クレアチンホスフエート8mMおよび牛血清アル
ブミン(BSA)0.2%含有100mMトリス塩酸塩緩
衝液(PH7.5)(以下B液と称す)に溶かし、これ
を標準品牛PTH(1−84)についても行う これら4つの溶液を50μlづつガラス試験管に分
注し、各々8本づつ用意する。試料は氷水中に保
ち、ATPなど他の物質の分解を抑える。−20℃に
保存したPTHレセプター調製品を室温で解凍し、
A液に予め溶かしておいてクレアチンキナーゼを
加え、さらにA液でクレアチンキナーゼ0.1mg/
ml、PTHレセプター調製品蛋白量1.4mg/mlにな
るように調製し、氷冷中で保つ。上記の分注され
た試料溶液を37℃の恒温槽に数分間つけた後に、
上記のPTHレセプター−クレアチンキナーゼ液
を50μlづつ加え、37℃で10分間インキユベートす
る。次いで0.1M酢酸緩衝液(PH4.0)100μlを加
え、直ちに氷水中につけた後、すみやかに試験管
を沸騰水で1分間熱し、反応を停止させる。 (3) 生成C−AMPの測定 上記の反応停止試料を蒸留水で10〜30倍に希釈
し、2000XG、15分間の遠心分離により除蛋白を
行う。その上清のC−AMP量をRIAキツト(ヤ
マサ醤油社製)で測定する。 (4) PTH力価の測定 C−AMPの測定値をPM/mgPTHレセプター
蛋白/分の単位に換算し、これを反応の値とし、
標準品によつて得られた値に対して被検品を平行
線検定2×2点法を用いて検定する。 (5) PTH活性結果(U/mg)
The present invention provides novel human parathyroid hormone (h-
PTH) derivatives. More specifically, the present invention provides a therapeutic agent for hypoparathyroidism, or
[Nle 8 , Nle 18 , Tyr 34 ]-h-PTH (1-34) useful as a therapeutic agent involving PTH or as a raw material for labeled compounds for testing parathyroid function
NH 2 , i.e. the formula H−S 1 er −V 2al −S 3 er −G 4 lu −I 5 le −G 6 lo −L 7 eu −N 8
is
A 10 so −L 11 eu −G 12ly −L 13 ys14is −L 15eu −A 16 so −S 1
7
er −N 18 le
G 19 lu −A 20 rg −V 21 al −G 22 lu −T 23 rp −L 24 eu −A 25 rg −L
26 ys −L 27 ys
−L 28 eu −G 29 lo −A 30 sp −V 31 al −H 32is −A 33 so −T 34 yr
−NH2
...[) (In the formula, Ser is L-serine, Val is L-valine,
Glu is L-glutamic acid, Ile is L-isoleucine, Gln is L-glutamine, Leu is L-leucine,
Nle is L-norleucine, His is L-histidine,
Asn is L-asparagine, Gly is glycine, Lys
is L-lysine, Arg is L-arginine, and Trp is L-lysine.
-Tryptophan, AsP is L-aspartic acid,
Tyr represents L-tyrosine) or a salt thereof. h-PTH is a peptide hormone consisting of 84 amino acids, and its biological activity is
-34 N-terminal fragment, namely h-PTH(1-
34) [Proc. Nat.
Acad.Sci.USA, 68 , 63-67 (1971)]. However, h-PTH is unstable due to the presence of L-methionine (Met), and its hormone activity is lost when labeled with I125 [Recent Prog.
Res., 18 , 269-295 (1962)]. In the conventional method for quantifying h-PTH, in order to quantify only the portion that has h-PTH activity,
A specific antibody using (1-34) as an antigen has now been prepared. However, h-PTH(1-34)
is unstable due to the presence of L-methionine (Met), and when labeled with I125 , Met present at positions 8 and 18 is oxidized, resulting in inactivation of the hormone activity. Therefore, as an h-PTH derivative that not only has PTH activity and immunoactivity against PTH antibodies, but also has stable hormonal activity even when labeled with I125 , and stable radioactivity, 8 Met at position and 18th position were replaced with L-norleucine, and L-phenylalanine at position 34 was replaced with L-tyrosine [N 8 le , N 18 le , T 34 yr 34 ]-h-PTH (1-34 ) was discovered [JP-A-55-113753]. However, this [N 8 le , N 18 le , T 34 yr ]−h−
Since PTH (1-34) does not have Met in its molecule, it is not inactivated even when labeled with I 125 , but its hormonal activity is at most the same as that of natural h-PTH (1-34). It had no more than a The target compound [] has the known h-PTH (1-34) and [N 8 le , N 18 le ,
T 34 yr ]-h-PTH (1-34) has a stronger affinity and not only has h-PTH activity approximately 1.5 to 2 times higher, but also has immunoactivity against PTH antibodies. However, labeling with I125 did not reduce hormone activity;
[N 8 le , N 18 yr , T 34 yr ]-h-PTH (1-34) about 2
It has twice the radioactivity and does not lose its biological activity even during long-term storage, so it has twice the radioactivity of the known h-PTH.
(1-34), [N 8 le , N 18 le , T 34 yr ]-h-PTH (1-
34) Demonstrate more extreme and superior effects. Therefore, the object compound [ ] is an extremely useful peptide as a raw material for a therapeutic agent for hypoparathyroidism, a therapeutic agent for bones involving PTH, and a labeled compound for testing parathyroid function. The peptide [] of the present invention has the formula []
Individual protected amino acids and/or protected lower peptides are condensed to the amino acid order shown by liquid phase synthesis, and in the final step of the condensation reaction, a protecting group for the N-terminal amino group and a functional group for the side chain are added. It can be obtained by removing the protective group of by acid decomposition. The condensation reaction itself is carried out by repeating the attachment/detachment of a protecting group and the condensation reaction according to a conventional method for peptide synthesis. That is, the various protecting groups used in the production of the raw materials of this peptide [] and all intermediates are those known in peptide synthesis;
Protecting groups are therefore used which are easily removable by known means such as hydrolysis, acid hydrolysis, reduction, aminolysis or hydrazinolysis. Such protecting groups are described in the literature and reference books in the field of peptide synthetic chemistry. For example, as a protecting group for an amino group,
Acyl groups such as formyl group, trifluoroacetyl group, phthaloyl group, p-toluenesulfonyl group, o-nitrophenylsulfenyl group, benzyloxycarbonyl group, o (or p)-bromobenzyloxycarbonyl group, o (or benzyloxycarbonyl group such as p)-chlorobenzyloxycarbonyl group, p-nitrobenzyloxycarbonyl group, p-methoxybenzyloxycarbonyl group, trichloroethyloxycarbonyl group, t
-Aliphatic oxycarbonyl groups such as butyloxycarbonyl group, t-amyloxycarbonyl group, diisopropylmethyloxycarbonyl group, 2
-phenyl-isopropoxycarbonyl group, 2-
Tolyl-isopropoxycarbonyl group, 2-p-
Examples include aralkyloxycarbonyl groups such as diphenyl-isopropoxycarbonyl groups. These amino groups can also be protected by forming enamines obtained by reacting with 1,3-diketones such as benzoylacetone and acetylacetone. Carboxyl groups are protected by amide formation, hydratide formation or esterification. That is, the amide group is substituted with a 3,4-dimethoxybenzyl group, a bis-(p-methoxyphenyl)methyl group, or the like. The hydratide group is substituted with a benzyloxycarbonyl group, a trichloroethyloxycarbonyl group, a trifluoroacetyl group, a t-butyloxycarbonyl group, a trityl group, a 2-p-diphenyl-isopropoxycarbonyl group, and the like. Ester groups include methanol, ethanol,
Alkanols such as t-butanol and cyanomethyl alcohol, benzyl alcohol, p-bromobenzyl alcohol, p-chlorobenzyl alcohol, 2,6-dichlorobenzyl alcohol, p
- aralkanols such as methoxybenzyl alcohol, p-nitrobenzyl alcohol, benzhydryl alcohol, benzoylmethyl alcohol, p-bromobenzoylmethyl alcohol, p-chlorobenzoylmethyl alcohol, 2,4,6
- substituted with phenols such as trichlorophenol, 2,4,5-trichlorophenol, pentachlorophenol, p-nitrophenol, 2,4-dinitrophenol, thiophenols such as thiophenol, p-nitrothiophenol, etc. Ru. The hydroxyl groups of serine and tyrosine can be protected, for example, by esterification or etherification. Groups suitable for this esterification include, for example, acetyl group, benzoyl group, benzyloxycarbonyl group, and ethyloxycarbonyl group. Examples of groups suitable for etherification include benzyl group, 2,6-dichlorobenzyl group, tetrahydropyranyl group, and t-butyl group. To protect these hydroxyl groups, 2,2,2-trifluoro-1-t-butyloxycarbonylaminoethyl group, 2,2,2-trifluoro-1-
Benzyloxycarbonylamino groups are also suitable. However, it is not necessary to protect these hydroxyl groups. Groups used to protect the amino group in the guanidino group of arginine include, for example, a nitro group, a tosyl group, a benzyloxycarbonyl group, a mesitylene-2-sulfonyl group, but the guanidino group is not necessarily protected. There's no need. Examples of the group used to protect the imino group of histidine include benzyl group, trityl group, benzyloxycarbonyl group, tosyl group,
2,2,2-trifluoro-1-t-butyloxycarbonylaminoethyl group, 2,2,2-trifluoro-1-benzyloxycarbonylaminoethyl group, etc., but this imino group is not necessarily protected. do not have to. In the present invention, t-
A butyloxycarbonyl group or a t-amyloxycarbonyl group is used, an o-chlorobenzyloxycarbonyl group is used to protect the side chain amino group, i.e. the ξ-amino group of lysine, and a benzyl ester group is used to protect the α-carboxyl group. , an ethyl ester group, a phenacyl ester group, a benzyl ester group is used to protect the side chain carboxyl group of glutamic acid and aspartic acid, a benzyl group is used to protect the hydroxyl group of serine, and a benzyl group is used to protect the hydroxyl group of tyrosine. It is preferable to use a 2,6-dichlorobenzyl group for the protection of arginine, and to use a tosyl group or a mesitylene-2-sulfonyl group for the protection of the amino group in the guanidino group of arginine. In the synthesis of the target compound [], condensation of individual amino acids and/or lower peptides is performed, for example, with an amino acid or peptide having a protected α-amino group and an activated terminal carboxyl group, and a free α-amino group and An amino acid or peptide with a protected terminal carboxyl group is reacted with an amino acid or peptide with an activated α-amino group and a protected terminal carboxyl group with a free terminal carboxyl group and a protected α-amino group. This can be carried out by reacting amino acids or peptides with groups. In this case, the carboxyl group is, for example, an acid azide, an acid anhydride, an acid imidazolide or an active ester, such as cyanomethyl ester, thiophenyl ester, p-nitrothiophenyl ester, p
-Nitrophenyl ester, 2,4-dinitrophenyl ester, 2,4,5-trichlorophenyl ester, 2,4,6-trichlorophenyl ester, pentachlorophenyl ester, N-hydroxysuccinimide ester, It can be activated by converting it into N-hydroxyphthalic acid imide ester or the like. Condensing agents such as carbodiimides, such as N,N'-dicyclohexyl-carbodiimide, N-ethyl-N'-3-dimethylaminopropyl-carbodiimide, N,N'-carbonyl-diimidazole or isoxolium salts, such as Woodward reagents, may also be used. It can be activated by using and reacting. Preferred condensation methods in the present invention are the azide method, active ester method and carbodiimide method. In each step of the condensation, it is desirable to use a method that does not cause racemization or a method that minimizes racemization, preferably the azide method, active ester method, Biunsch method [Z.Naturforsch., 21b, 426 (1966)] or Geiger method [Chem Ber., 103, 788 (1970)]
In particular N-ethyl-N'-3-dimethylaminopropyl-carbodiimide (WSC) as condensing agent.
It is appropriate to use a modified method using . The condensation order can be synthesized in any order as long as it is the amino acid order shown by the formula [], but C-
It is preferable to connect amino acids and/or peptides sequentially from the terminal side. For example, it is preferable to condense a C-terminal fragment consisting of amino acids 29 to 34 with a peptide fragment consisting of amino acids 23 to 28. Condensation of this C-terminal fragment with hexapeptide 23-28 is suitably carried out by a modified Geiger method using WSC. A peptide fragment consisting of amino acids 18 to 22 is linked in front of the C-terminal fragment 23-34 obtained, which is suitably carried out by a modified Geiger method using WSC. The obtained C-terminal fragment 18-34 was preceded by a peptide fragment consisting of amino acids 13 to 17, a peptide fragment consisting of amino acids 8 to 12, and a peptide fragment consisting of amino acids 1 to 7. It is preferable to connect them. A protecting group for α-amino group in the above condensation reaction, such as t-butyloxycarbonyl group, t-
The amyloxycarbonyl group is removed with trifluoroacetic acid. Protecting groups for α-carboxyl groups, such as ethyl ester, can be decomposed with dilute sodium hydroxide solution or converted into protected hydratides such as hydratide or trichloroethoxycarbonyl hydratide, and phenacyl ester groups can be removed with Zn powder in acetic acid. The benzyl ester group can also be decomposed by anhydrous hydrogen fluoride decomposition, hydrogenolysis, or converted to a hydratide. The N-terminal α-amino group thus protected, ξ-
A tetratriacontapeptide having an amino group, a side chain carboxyl group, a guanidino group and/or a hydroxyl group is obtained. These protecting groups are preferably removed in one step by acid decomposition, such as with anhydrous hydrogen fluoride or trifluoromethanesulfonic acid, to yield the target compound of formula []. The peptide [] thus obtained can be separated and purified by known means for purifying peptides or proteins. For example, it can be carried out by gel filtration using a gelling agent such as Cephadex G-25, Cephadex G-50, Cephadex LH-20, column chromatography using carboxymethyl cellulose, ion exchange resin, etc., high performance liquid chromatography, etc. can. The peptide [] of the present invention can be obtained in the form of a base or its salt depending on the conditions of the method, including inorganic acid salts, formic acid, acetic acid, propionic acid, glycolic acid, succinic acid, malic acid, tartaric acid, citric acid. It is a salt with an organic acid such as. The present peptide [ ] can be added with certain inorganic or organic substances to form a complex. This complex refers to a compound of unknown composition that is formed upon addition and that confers a sustained effect on the peptide. Such substances include, for example, inorganic compounds derived from metals such as calcium, magnesium, aluminium, cobalt or zinc, especially slightly soluble phosphates, pyrophosphates or polyphosphates of these metals. salts and hydroxide compounds,
Alternatively, alkali metal polyphosphates can be mentioned. Furthermore, the peptide [] of the present invention preferably has
Used as a labeling reagent for RIA. For example, a 125 I-containing phosphate buffer (PH
Add the peptide of the present invention [] and chloramine T to 7.1), stir, then add sodium bisulfite, and then add a small amount of potassium iodide and serum albumin to perform chromatography.
By collecting the 125 I-labeled fractions, the 125 I-labeled radioactive substance is obtained. Next, the peptide of the present invention [] and radioactive parathyroid hormone (PTH) labeled with 125 I
Let's talk about activity. <Preparation of 125 I-labeled substance> Contains 125 I-NaI with 2 mCi of radioactivity
h-PTH in 50μl of 0.5M phosphate buffer (PH7.1)
(1-34), h-PTH( 1-34 ) NH2 , [ H8le ,
N 18 le , T 34 yr ]−h−PTH(1−34) and [N 8 le ′,
After adding 10 μl of a solution containing 2 μg of N 18 le , T 34 yr ]-h-PTH(1-34)NH 2 and 20 μl of a solution containing chloramine T (3.5-mg/ml) and stirring for 30 seconds, bisulfite was added. The reaction was stopped by adding 50 μl of a solution containing sodium (4.5 mg/ml). After adding 0.5 ml of 0.1N acetic acid solution containing 5% human serum albumin to this, it was charged to a Sephadex G-10 column (1 x 50 cm).
Elution was performed with the above acetic acid solution to obtain fractions containing each test product labeled with 125 I. <PTH activity measurement method> (1) Preparation of PTH receptor SD male rats (weighing 200-250 g) were decapitated and exsanguinated. After laparotomy, the kidney was removed, its surface membrane was removed, and the renal cortex was cut out. Cool on ice. The following operations are performed at as low a temperature as possible (0 to 4°C).
Add 0.25M sucrose and
10mM Tris-HCl buffer containing 1mM MEDTA (PH
7.5) (hereinafter referred to as Solution A), and homogenize the kidney cortex by adding 3 times the volume (ml) of Solution A to its wet weight (g) using a glass jacket tube using Teflon petals. The homogenate is centrifuged at 150Xg for 10 minutes, and the supernatant is further centrifuged at 2200Xg for 15 minutes. Discard the supernatant, suspend the upper cloudy part of the precipitate in Solution A, and add this suspension to 2200X.
g, washed by centrifugation for 155 minutes, resuspended and dispensed into containers, frozen at -70°C and stored at -20°C. (2) Reaction between PTH and PTH receptor Test product was mixed with ATPMg 2mM, MgCl 2 10mM, KCl 60mM,
GTP 20μM, isobutylmethylxanthine 1mM,
Dissolve in 100mM Tris-HCl buffer (PH7.5) containing 8mM creatine phosphate and 0.2% bovine serum albumin (BSA) (hereinafter referred to as solution B), and perform the same procedure on the standard bovine PTH (1-84). Dispense 50 μl of each of the four solutions into glass test tubes, and prepare 8 tubes of each. The sample is kept in ice water to prevent the decomposition of other substances such as ATP. The PTH receptor preparation stored at −20°C was thawed at room temperature.
Dissolve creatine kinase in Solution A in advance, add creatine kinase, and add 0.1mg/creatine kinase in Solution A.
ml, PTH receptor preparation protein amount is 1.4 mg/ml and kept on ice. After placing the above dispensed sample solution in a constant temperature bath at 37℃ for several minutes,
Add 50 μl of the above PTH receptor-creatine kinase solution and incubate at 37°C for 10 minutes. Next, add 100 μl of 0.1M acetate buffer (PH4.0) and immediately place the test tube in ice water. Immediately heat the test tube in boiling water for 1 minute to stop the reaction. (3) Measurement of produced C-AMP The above reaction-stopped sample is diluted 10 to 30 times with distilled water, and protein is removed by centrifugation at 2000XG for 15 minutes. The amount of C-AMP in the supernatant is measured using an RIA kit (manufactured by Yamasa Soy Sauce Co., Ltd.). (4) Measurement of PTH titer Convert the measured value of C-AMP to the unit of PM/mg PTH receptor protein/min, use this as the reaction value,
Test the test product against the values obtained with the standard product using a parallel line test 2 x 2 point method. (5) PTH activity results (U/mg)

【表】 本明細書中に記載の略記号は次の意味を有す
る。 Ser;L−セリン Val;L−バリン Glu;L−グルタミン酸 Ile;L−イソロイシン Gln;L−グルタミン Leu;L−ロイシン Nle;L−ノルロイシン His;L−ヒスチジン Asn;L−アスパラギン Gly;グリシン Lys;L−リジン Arg;L−アルギニン Trp;L−トリプトフアン Asp;L−アスパラギン酸 Tyr;L−チロシン Boc;t−ブチルオキシカルボニル Aoc;t−アミルオキシカルボニル Z−Cl;o−クロロベンジルオキシカルボニル Bzl;ベンジル Bzl−Cl2;2,6−ジクロロベンジル Tos;トシル OEt;エチルエステル OBzl;ベンジルエステル ONP;p−ニトロフエニルエステル OPAC;フエナシルエステル TFA;トリフルオロ酢酸 TosOH;p−トルエンスルホン酸 Et3N;トリエチルアミン NMM;N−メチルモルホリン TBA;t−ブチルアミン DCHA;ジシクロヘキシルアミン NaOH;水酸化ナトリウム THF;テトラヒドロフラン DMF;ジメチルホルムアミド DMSO;ジメチルスルホキシド エーテル;ジエチルエーテル DCC;N,N′−ジシクロヘキシルカルボジジ
イミド WSC;N−エチル,N′−3−ジメチルアミノ
プロピル−カルボジイミド HOBt;1−ヒドロキシベンゾトリアゾール PEE( );PFは保護されたアミノ酸またはペ
プチドフラグメントを意味し、()内の数字は式
〔〕のアミノ酸の順序を示す。 次に実施例を挙げて本発明の製造例を具体的に
説明する。 尚、実施例で使用した薄層クロマトグラフイー
(TLC)の担体および展開溶媒系ならびにアミノ
酸分析の条件は次の通りである。 <TLC> 担体;シリカゲルG 展開溶媒系; 1 クロロホルム−メタノール−酢酸(95:5:
3)、 2 クロロホルム−メタノール−酢酸(85:15:
5)、 3 クロロホルム−メタノール−酢酸(80:25:
2)、 4 クロロホルム−エタノール−酢酸エチル
(5:2:5)、 5 ヘキサン−酢酸エチル(1:1) 担体;セルロース(メルク社製,DC−
Alufolien) 展開溶媒系; 6 ブタノール−ピリジン−酢酸−水(5:3:
0.1:11)の上層 <アミノ酸分析> 特記しない限り、試料は6N塩酸で110℃、24〜
48時間封管中で加水分解した。 実施例 1 〔Nle8,Nle18,Tyr34〕−h−PTH(1−34)
NH2の製造 1) PF(34);Boc−Tyr(Bzl−Cl2)−NH2
〔〕 Boc−Tyr(Bzl−Cl2)−OH52.84g(0.12M)
とp−ニトロフエノール16.69g(0.12M)を乾
燥TH下に溶かし、これに−5℃で冷却下
DCC24.76g(0.12M)の乾燥THF溶液を滴下し
た後、一夜撹拌した。反応後、析出物を去し、
液にNH3ガスを飽和し、5時間撹拌した。沈
澱物が生じるが、DMFを加えて溶解した後、減
圧濃縮した。残渣をエーテルから結晶化した後、
取、乾燥して目的物〔1〕を得た。 収量;44.77g(収率84.9%) 融点;214〜216℃ TLC;Rf1=0.62 元素分析〔C21H24O4N2Cl2として〕 C% H% N% 計算値 57.41 5.51 6,38 測定値 57.42 5.59 6.51 〔α〕25 D−5.54゜(C=1,DMF) 2) PF(33−34);Boc−Asn−Tyr(Bzl−Cl2
−NH2〔2〕 化合物〔1〕26.36g(60mM)を塩化メチレ
ンに溶かし、これに氷冷下TFA100mlを加えた
後、室温で30分間撹拌した。反応後、塩化メチレ
ンとTFAを減圧下留去し、残渣をエーテルで結
晶化した後、取、乾燥した。得られた結晶、
Boc−Asn−OH13.93g(60mM)および
HOBt8.1g(60mM)をDMFに溶かし、これに
−15℃で冷却下WSC10.98ml(60mM)を加えた
後、一夜撹拌した。反応後、沈澱物を取し、5
%重曹水(1回)、水(2回)、メタノール(1
回)の順で洗浄し、乾燥して目的物〔2〕の結晶
を得た。母液は減圧下DMFを留去し、得られた
結晶を水、メタノールの順で洗浄し、乾燥して化
合物〔2〕を得、先の目的物〔2〕と合せた。 収量;28.64g(収率86.25%) 融点;240〜242℃ 〔α〕25 D−24.06゜(C=1,DMF) 元素分析〔C24H30O6N4Cl2として〕 C% H% N% 計算値 54.25 5.46 10.13 測定値 54.46 5.38 10.31 3) PF(32−34);Boc−His(Tos)−Asn−
Tyr(Bzl−Cl2)−NH2〔3〕 化合物〔2〕22.14g(40mM)を少量の塩化
メチレンに溶かし、これに氷冷下TFA100mlを加
え、室温で30分間撹拌した後、TFAを減圧下留
去して脱Boc化物を得た。 一方、Boc−His(Tos)−OH・DCHA28.36g
(48mM)を酢酸エチル500mlに懸濁し、1N硫酸
で2回、水で2回の順に洗浄し、無水芒硝で乾燥
した後、減圧下酢酸エチルを留去した。残渣を乾
燥DMFに溶かし、これに前記脱Boc化物の乾
DMF溶液およびNOBt6.48g(48mM)を加え、
次いで、−15℃で冷却下WSC8.78ml(48mM)を
加えた後、室温で一夜撹拌した。反応後、減圧下
DMFを留去し、残渣を5%重曹水で1回、水で
2回の順に洗浄した後、乾燥して粗生成物を得
た。これをメタノール−エーテルから結晶化して
目的物〔3〕を得た。結晶母液を減圧濃縮し、残
渣をメタノール−ヘキサンから結晶化して化合物
〔3〕を得、先の目的物〔3〕と合せた。 収量;28.81g(収率85.1%) 融点;170〜175℃ TLC;Rf3=0.68、0.42 一部Tosが脱離したものが得られた。 元素分析〔C38H44O9N7Cl2Sとして〕 C% H% N% 計算値 53.96 5.24 11.59 測定値 53.03 5.65 12.04 4) PF(31−34);Boc−Val−His−Asn−
Tyr(Bzl−Cl2)−NH2〔4〕 化合物〔3〕28.81g(34.06mM)を少量の塩
化メチレンに溶かし、これに氷冷下TFA120mlを
加え、室温で30分撹拌した後、TFAを減圧下留
去した。残渣にエーテルを加え、析出した結晶を
取、乾燥後、DMF140mlに溶解した。この溶液
をNMMで中和し、これにBoc−Val−OH8.14g
(37.47mM)およびHOBt5.06g(37.47mM)を
乾燥DMF60mlに溶解した溶液を加え、次いで−
15℃で冷却下WSC6.86ml(37.47mM)を加え、
室温で一夜撹拌した。反応後、減圧下DMFを留
去し、残渣を5%重曹水で1回、水で3回洗浄
し、乾燥して目的物〔4〕を得た。 収量27.76g(収率103.2%) 融点;164〜166℃ TLC;Rf3=0.65 〔α〕25 D−28.38゜(C=1,DMF) 元素分析〔C36H46O8Cl2として〕 C% H% N% 計算値 54.75 5.87 14.19 測定値 53.37 5.87 13.43 5) PF(30−34);Boc−Asp(OBzl)−Val−
His−Asn−Tyr(Bzl−Cl2)−NH2〔5〕 化合物〔4〕27.76g(35.15mM)を少量の塩
化メチレンに懸濁し、これに氷冷下TFA110mlを
加え、室温で30分間撹拌した後、TFAを減圧下
留去した。残渣にエーテルを加え、析出した結晶
を取、乾燥後、DMF120mlに溶解した。この溶
液をNMM10mlを加えて中和し、これにBoc−
Asp(OBzl)−OH12.5g(38.67mM)および
HOBt5.22g(38.67mmM)を乾燥DMF80mlに溶
解した溶液を加え、次いで−15℃で冷却下
WSC7.08ml(38.67mM)を加えた後、室温で一
夜撹拌した。反応後、減圧下DMFを留去し、残
渣を5%重曹水で1回、水で2回洗浄した後、メ
タノールに懸濁しエーテテルを加えて再結晶化し
て目的物〔5〕を得た。 収量;31.42g(収率89.8%) 融点;214〜215℃ TLC;Rf3=0.6 〔α〕25 D−23.28゜(C=1,DMF) 元素分析〔C47H57O11N9Cl2として〕 C% H% N% 計算値 56.74 5.78 12.67 測定値 56.19 5.79 12.07 6) PF(29−34);Boc−Gln−Asp(OBzl)−
Val−His−Asn−Tyr(Bzl−Cl2)−NH2〔6〕 化合物〔5〕31.11g(31.27mM)を塩化メチ
レンに懸濁し、これに氷冷下TFA120mlを加え、
室温で30分間撹拌した後、TFA、塩化メチレン
を減圧下留去した。残渣エーテルを加え、析出し
た結晶を取、乾燥後、乾燥DMF100mlに溶解し
た。この溶液をNMM8mlで中和し、これにBoc
−Gln−ONP12.64g(34.4mM)および
HOBt0.42g(3.13mM)を乾燥DMF100mlに溶
解した溶液を加え、次いで氷冷下NMM3.78mlを
加えた後、一夜撹拌した。反応後、減圧下DMF
を留去し、残渣を5%重曹水で1回、水で2回洗
浄した後、メタノールに懸濁し、エーテルで再結
晶化して目的物〔6〕を得た。 収量;33.19g(収率94.5%) 融点;81〜83℃ TLC;Rf3=0.47 〔α〕24 D−23.98゜(C=1,DMF) 元素分析〔C52H65O13N11Cl2として〕 C% H% N% 計算値 55.61 5.83 13.72 測定値 54.81 5.96 13.07 アミノ酸分析;Asp2.19(2)、Glu1.05(1)、Val/
(1)、Tyr0.73(1)、His0.85(1) 7) PF(27−28);Boc−Lys(Z−Cl)−Leu−
OEt〔7〕 Boc−Lys(Z−Cl)−OH・TBA97.6g
(0.2M)を酢酸エチル500mlに懸濁し、これを1N
塩酸、水の順で洗浄し、無水芒硝で乾燥した後、
減圧濃縮して油状物を得た。これを乾燥THF500
mlに溶かし、これにH−Leu−OEt・HCl39.14g
(0.2M)およびHOBt27.0g(0.2M)を加え、次
いで−15℃に冷却下WSC36.6ml(0.2M)を加え
た後、室温で一夜撹拌した。反応後、減圧THF
を留去した。残残渣を酢酸エチル600mlに溶かし、
5%重曹水、水、1N塩酸、水の順で洗浄し、無
水芒硝で乾燥後、減圧濃縮した。残渣を冷所で放
置して結晶化させた。ヘキサンを加えて取して
目的物〔7〕を得た。 収量;110.62g(収率99.5%) 融点;77〜80℃ TLC;Rf5=0.48 〔α〕29 D−19.08゜(C=1,DMF) 8) PF(26−28);Boc−Lys(Z−Cl)−Lys
(Z−Cl)−Leu−OEt〔8〕 化合物〔7〕110.62g(0.199M)を塩化メチ
レン50mlに加え、これに氷冷下TFA250mlを加え
た後、室温で1時間撹拌した。反応後、減圧下
TFA、塩化メチレンを留去して油状の脱Boc化
物を得た。 一方、Boc−Lys(Z−Cl)−OH・TBA97.1g
(0.199M)を酢酸エチル500mlに懸濁し、1N塩酸
300ml、水の順で洗浄し、無水芒硝で乾燥後、減
圧濃縮して油状物を得る。これを乾燥THF150ml
に溶かし、これに前記の脱Boc化物および
HOBt26.9g(0.199M)を乾燥THF250mlに溶解
した溶液を加え、次いで−15℃に冷却下
WSC36.4ml(0.199M)を滴下した後、室温で一
夜撹拌した。反応後、THFを減圧留去すると寒
天状結晶が析出した。これを酢酸エチルに溶か
し、5%重曹水、水、1N塩酸、水の順に洗浄し、
無水芒硝で乾燥後、減圧濃縮した。生じた沈澱物
をヘキサンで処理した後、取した。これを酢酸
エチル、エーテル、ヘキサンから再結晶して目的
物〔8〕を得た。 収量;156.52g(収率92.2%) 融点;114〜116℃ TLC;Rf2=0.78 〔α〕28 D−20.72゜(C=1,DMF) 9) PF(25−28);Aoc−Arg(Tos)−Lys(Z
−Cl)−Lys(Z−Cl)−Leu−OEt
[Table] The abbreviations described herein have the following meanings. Ser; L-serine Val; L-valine Glu; L-glutamic acid Ile; L- isoleucine Gln; L-glutamine L eu; L-leucine Nle ; L-norleucine His; L-histidine Asn; L-asparagine Gly ; Glycine Lys; L-lysine Arg; L-arginine Trp; L-tryptophan Asp; L-aspartic acid Tyr; L-tyrosine Boc; t-butyloxycarbonyl Aoc; t-amyloxycarbonyl Z-Cl; o-chlorobenzyl Oxycarbonyl Bzl; benzyl Bzl-Cl 2 ; 2,6-dichlorobenzyl Tos; tosyl OEt; ethyl ester OBzl; benzyl ester ONP; p-nitrophenyl ester OPAC; phenacyl ester TFA; trifluoroacetic acid TosOH; p-toluene Sulfonic acid Et 3 N; triethylamine NMM; N-methylmorpholine TBA; t-butylamine DCHA; dicyclohexylamine NaOH; sodium hydroxide THF; tetrahydrofuran DMF; dimethylformamide DMSO; dimethylsulfoxide ether; diethyl ether DCC; N,N'-dicyclohexyl Carbodidiimide WSC; N-ethyl, N'-3-dimethylaminopropyl-carbodiimide HOBt; 1-hydroxybenzotriazole PEE ( ); PF means protected amino acid or peptide fragment, numbers in parentheses are formula The order of amino acids in [] is shown. Next, production examples of the present invention will be specifically explained with reference to Examples. The carrier and developing solvent system for thin layer chromatography (TLC) used in the Examples and the conditions for amino acid analysis are as follows. <TLC> Support: Silica gel G Developing solvent system: 1 Chloroform-methanol-acetic acid (95:5:
3), 2 Chloroform-methanol-acetic acid (85:15:
5), 3 Chloroform-methanol-acetic acid (80:25:
2), 4 Chloroform-ethanol-ethyl acetate (5:2:5), 5 Hexane-ethyl acetate (1:1) Support: Cellulose (manufactured by Merck & Co., DC-
Alufolien) Developing solvent system; 6 Butanol-pyridine-acetic acid-water (5:3:
0.1:11) Upper layer <Amino acid analysis> Unless otherwise specified, samples were prepared with 6N hydrochloric acid at 110℃, 24~
Hydrolyzed in a sealed tube for 48 hours. Example 1 [Nle 8 , Nle 18 , Tyr 34 ]-h-PTH (1-34)
Production of NH 2 1) PF (34); Boc−Tyr(Bzl−Cl 2 )−NH 2
[] Boc-Tyr (Bzl-Cl 2 )-OH52.84g (0.12M)
and 16.69 g (0.12 M) of p-nitrophenol were dissolved in dry TH and cooled at -5°C.
A dry THF solution of 24.76 g (0.12 M) of DCC was added dropwise, and the mixture was stirred overnight. After the reaction, remove the precipitate,
The liquid was saturated with NH 3 gas and stirred for 5 hours. A precipitate was formed, which was dissolved by adding DMF and then concentrated under reduced pressure. After crystallizing the residue from ether,
The product was collected and dried to obtain the desired product [1]. Yield: 44.77g (yield 84.9%) Melting point: 214-216℃ TLC; Rf 1 = 0.62 Elemental analysis [as C 21 H 24 O 4 N 2 Cl 2 ] C% H% N% Calculated value 57.41 5.51 6,38 Measured value 57.42 5.59 6.51 [α] 25 D −5.54゜ (C=1, DMF) 2) PF (33−34); Boc−Asn−Tyr (Bzl−Cl 2 )
-NH2[ 2 ] 26.36g (60mM) of compound [1] was dissolved in methylene chloride, and 100ml of TFA was added thereto under ice-cooling, followed by stirring at room temperature for 30 minutes. After the reaction, methylene chloride and TFA were distilled off under reduced pressure, and the residue was crystallized with ether, then taken and dried. the obtained crystals,
Boc-Asn-OH13.93g (60mM) and
8.1g (60mM) of HOBt was dissolved in DMF, and 10.98ml (60mM) of WSC was added thereto under cooling at -15°C, followed by stirring overnight. After the reaction, remove the precipitate and
% sodium bicarbonate solution (1 time), water (2 times), methanol (1 time)
The crystals were washed in the following order and dried to obtain crystals of the desired product [2]. DMF was distilled off from the mother liquor under reduced pressure, and the obtained crystals were washed with water and methanol in that order and dried to obtain compound [2], which was combined with the target product [2]. Yield: 28.64g (yield 86.25%) Melting point: 240-242℃ [α] 25 D -24.06゜ (C = 1, DMF) Elemental analysis [as C 24 H 30 O 6 N 4 Cl 2 ] C% H% N% Calculated value 54.25 5.46 10.13 Measured value 54.46 5.38 10.31 3) PF(32−34);Boc−His(Tos)−Asn−
Tyr(Bzl-Cl 2 )-NH 2 [3] Compound [2] 22.14g (40mM) was dissolved in a small amount of methylene chloride, 100ml of TFA was added under ice cooling, and after stirring at room temperature for 30 minutes, TFA was removed under reduced pressure. The residue was distilled off to obtain a Boc-free product. On the other hand, Boc-His(Tos)-OH・DCHA28.36g
(48mM) was suspended in 500ml of ethyl acetate, washed twice with 1N sulfuric acid and twice with water, dried over anhydrous sodium sulfate, and then ethyl acetate was distilled off under reduced pressure. Dissolve the residue in dry DMF and add the dried Boc-removed product to this.
Add DMF solution and NOBt6.48g (48mM),
Next, 8.78 ml (48 mM) of WSC was added while cooling at -15°C, and the mixture was stirred at room temperature overnight. After reaction, under reduced pressure
DMF was distilled off, and the residue was washed once with 5% aqueous sodium bicarbonate and twice with water, and then dried to obtain a crude product. This was crystallized from methanol-ether to obtain the desired product [3]. The crystal mother liquor was concentrated under reduced pressure, and the residue was crystallized from methanol-hexane to obtain compound [3], which was combined with the target compound [3]. Yield: 28.81 g (yield 85.1%) Melting point: 170-175°C TLC: Rf 3 =0.68, 0.42 A product was obtained in which Tos was partially eliminated. Elemental analysis [as C 38 H 44 O 9 N 7 Cl 2 S] C% H% N% Calculated value 53.96 5.24 11.59 Measured value 53.03 5.65 12.04 4) PF (31−34); Boc−Val−His−Asn−
Tyr(Bzl-Cl 2 )-NH 2 [4] Compound [3] 28.81g (34.06mM) was dissolved in a small amount of methylene chloride, 120ml of TFA was added under ice cooling, and after stirring at room temperature for 30 minutes, TFA was dissolved. It was distilled off under reduced pressure. Ether was added to the residue, and the precipitated crystals were collected, dried, and then dissolved in 140 ml of DMF. This solution was neutralized with NMM, and 8.14 g of Boc-Val-OH was added to it.
(37.47mM) and HOBt5.06g (37.47mM) dissolved in 60ml of dry DMF were added, and then -
Add 6.86ml (37.47mM) of WSC while cooling at 15℃.
Stir overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and the residue was washed once with 5% aqueous sodium bicarbonate and three times with water, and dried to obtain the target product [4]. Yield 27.76g (yield 103.2%) Melting point: 164-166℃ TLC; Rf 3 = 0.65 [α] 25 D -28.38゜ (C = 1, DMF) Elemental analysis [as C 36 H 46 O 8 Cl 2 ] C % H% N% Calculated value 54.75 5.87 14.19 Measured value 53.37 5.87 13.43 5) PF(30−34);Boc−Asp(OBzl)−Val−
His-Asn-Tyr(Bzl- Cl2 ) -NH2 [5] Compound [4] 27.76g (35.15mM) was suspended in a small amount of methylene chloride, 110ml of TFA was added under ice-cooling, and the mixture was stirred at room temperature for 30 minutes. After that, TFA was distilled off under reduced pressure. Ether was added to the residue, and the precipitated crystals were collected, dried, and then dissolved in 120 ml of DMF. Neutralize this solution by adding 10ml of NMM, and add Boc-
Asp(OBzl)-OH12.5g (38.67mM) and
A solution of 5.22 g (38.67 mmM) of HOBt dissolved in 80 ml of dry DMF was added and then cooled at -15℃.
After adding 7.08 ml (38.67 mM) of WSC, the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, and the residue was washed once with 5% aqueous sodium bicarbonate and twice with water, suspended in methanol, and recrystallized by adding ether to obtain the target product [5]. Yield: 31.42g (yield 89.8%) Melting point: 214-215℃ TLC: Rf 3 = 0.6 [α] 25 D -23.28゜ (C = 1, DMF) Elemental analysis [C 47 H 57 O 11 N 9 Cl 2 ] C% H% N% Calculated value 56.74 5.78 12.67 Measured value 56.19 5.79 12.07 6) PF (29−34); Boc−Gln−Asp(OBzl)−
Val-His-Asn-Tyr(Bzl- Cl2 ) -NH2 [6] Compound [5] 31.11g (31.27mM) was suspended in methylene chloride, and 120ml of TFA was added under ice-cooling.
After stirring at room temperature for 30 minutes, TFA and methylene chloride were distilled off under reduced pressure. The residual ether was added, and the precipitated crystals were collected, dried, and then dissolved in 100 ml of dry DMF. Neutralize this solution with 8 ml of NMM and add Boc
-Gln-ONP12.64g (34.4mM) and
A solution of 0.42 g (3.13 mmol) of HOBt dissolved in 100 ml of dry DMF was added, and then 3.78 ml of NMM was added under ice cooling, followed by stirring overnight. After reaction, DMF under reduced pressure
was distilled off, and the residue was washed once with 5% aqueous sodium bicarbonate and twice with water, suspended in methanol, and recrystallized with ether to obtain the desired product [6]. Yield: 33.19g (yield 94.5%) Melting point: 81-83℃ TLC: Rf 3 = 0.47 [α] 24 D -23.98゜ (C = 1, DMF) Elemental analysis [C 52 H 65 O 13 N 11 Cl 2 ] C% H% N% Calculated value 55.61 5.83 13.72 Measured value 54.81 5.96 13.07 Amino acid analysis; Asp2.19(2), Glu1.05(1), Val/
(1), Tyr0.73(1), His0.85(1) 7) PF(27−28); Boc−Lys(Z−Cl)−Leu−
OEt [7] Boc-Lys(Z-Cl)-OH・TBA97.6g
(0.2M) was suspended in 500ml of ethyl acetate, and this was added to 1N
After washing with hydrochloric acid and water in that order and drying with anhydrous sodium sulfate,
Concentration under reduced pressure gave an oil. Dry this with THF500
ml and add 39.14 g of H-Leu-OEt・HCl to this.
(0.2M) and 27.0g (0.2M) of HOBt were added, and then 36.6ml (0.2M) of WSC was added while cooling to -15°C, followed by stirring at room temperature overnight. After reaction, THF under reduced pressure
was removed. Dissolve the remaining residue in 600ml of ethyl acetate,
The mixture was washed with 5% sodium bicarbonate solution, water, 1N hydrochloric acid, and water in this order, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. The residue was left in the cold to crystallize. Hexane was added and removed to obtain the desired product [7]. Yield: 110.62g (yield 99.5%) Melting point: 77-80℃ TLC; Rf 5 = 0.48 [α] 29 D -19.08゜ (C = 1, DMF) 8) PF (26-28); Boc-Lys ( Z−Cl)−Lys
(Z-Cl)-Leu-OEt [8] 110.62 g (0.199 M) of compound [7] was added to 50 ml of methylene chloride, and to this was added 250 ml of TFA under ice cooling, followed by stirring at room temperature for 1 hour. After reaction, under reduced pressure
TFA and methylene chloride were distilled off to obtain an oily de-Boc product. On the other hand, Boc-Lys(Z-Cl)-OH・TBA97.1g
(0.199M) in 500ml of ethyl acetate and 1N hydrochloric acid.
Wash with 300 ml of water and dry with anhydrous sodium sulfate, then concentrate under reduced pressure to obtain an oil. Dry this with THF150ml
and add the above-mentioned de-Boc compound and
A solution of 26.9 g (0.199 M) of HOBt dissolved in 250 ml of dry THF was added and then cooled to -15℃.
After 36.4 ml (0.199 M) of WSC was added dropwise, the mixture was stirred at room temperature overnight. After the reaction, THF was distilled off under reduced pressure to precipitate agar-like crystals. Dissolve this in ethyl acetate, wash with 5% sodium bicarbonate solution, water, 1N hydrochloric acid, and water in this order.
After drying with anhydrous sodium sulfate, the mixture was concentrated under reduced pressure. The resulting precipitate was treated with hexane and then collected. This was recrystallized from ethyl acetate, ether, and hexane to obtain the desired product [8]. Yield: 156.52g (yield 92.2%) Melting point: 114-116℃ TLC; Rf 2 = 0.78 [α] 28 D -20.72゜ (C = 1, DMF) 9) PF (25-28); Aoc-Arg ( Tos)−Lys(Z
−Cl)−Lys(Z−Cl)−Leu−OEt

〔9〕 化合物〔8〕156.5g(184mM)を塩化メチレ
ン50mlに加え、これに氷冷下TFA250mlを加えた
後、室温で1時間撹拌した。反応液を減圧濃縮
し、残渣を乾燥DMF300mlに溶かした後、NMM
で中和した。これにAoc−Arg(Tos)−OH86.0g
(202mM)を乾燥DMF100mlに溶解した溶液およ
びHOBt27.3g(202mM)を加え、次いで−15℃
に冷却下WSC37.0ml(202mM)を滴下した後、
室温で一夜撹拌した。反応後、DMFを減圧留去
し、残渣を酢酸エチル1lに溶解した。この溶液を
5%重曹水で2回、飽和食塩水、1N塩酸で2回、
飽和食塩水の順で洗浄し、無水芒硝で乾燥後、減
圧濃縮した。残渣にエーテルを加え、取し目的
[9] 156.5 g (184 mM) of compound [8] was added to 50 ml of methylene chloride, and to this was added 250 ml of TFA under ice cooling, followed by stirring at room temperature for 1 hour. After concentrating the reaction solution under reduced pressure and dissolving the residue in 300 ml of dry DMF, NMM
It was neutralized. Add this to Aoc−Arg(Tos)−OH86.0g
(202mM) dissolved in 100ml of dry DMF and 27.3g of HOBt (202mM) were added, and then -15℃
After dropping 37.0ml (202mM) of WSC under cooling into
Stir overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in 1 liter of ethyl acetate. This solution was mixed twice with 5% sodium bicarbonate solution, twice with saturated saline solution, and twice with 1N hydrochloric acid.
The mixture was washed with saturated brine, dried over anhydrous sodium sulfate, and concentrated under reduced pressure. Add ether to the residue and collect the target product.

〔9〕を得た。 収量;217.91g(収率100.6%) TLC;Rf1=0.09、Rf2=0.67 融点;75〜78℃ 〔α〕D 28−14.02゜(C=1,DMF) 10) PF(24−28);Boc−Leu−Arg(Tos)−
Lys(Z−Cl)−Lys:(Z−Cl)−Leu−OEt〔10〕 化合物
[9] was obtained. Yield: 217.91g (yield 100.6%) TLC: Rf 1 = 0.09, Rf 2 = 0.67 Melting point: 75-78°C [α] D 28 -14.02° (C = 1, DMF) 10) PF (24-28) ;Boc−Leu−Arg(Tos)−
Lys(Z-Cl)-Lys:(Z-Cl)-Leu-OEt[10] Compound

〔9〕217.9g(0.185M)に塩化メチレ
ン100mlおよびTFA250mlを加え、室温で80分間
撹権拌した後、減圧下塩化メチレンおよびTFA
を留去した。得られた油状物を乾燥DMF300mlに
溶かし、NMMを加えて中和した。この溶液に
Boc−Leu−OH・H2O50.9g(0.204M)および
HOBt27.6g(0.204M)を乾燥DMF100mlに溶解
した溶液を加え次いで−15℃で冷却下WSC37.3
ml(0.204M)を滴下した後、室温で一夜撹拌し
た。反応後、減圧下DMFを留去し、残渣を水に
加え、析出した生成物を取した。メタノール−
エーテル−ヘキサンから2回結晶化して目的物
〔10〕を得た。 収量;213.63g(収率90.5%) 融点;157〜160℃ TLC;Rf1=0.28、Rf2=0.77 〔α〕27 D−18.68゜(C=1,DMF) 11) PF(23−28);Boc−TrP−Leu−Arg
(Tos)−Lys(Z−Cl)−Lys:(Z−Cl)−Leu−
OEt〔11〕 化合物〔10〕153.17g(0.12M)に塩化メチレ
ン100mlおよびTFFA250mlを加え、室温で80分間
撹拌した後、減圧下塩化メチレンおよびTFAを
留去した。残渣を乾燥DMF250mlに溶かし、
NMMでPH7に中和した。この溶液にHOBt17.84
g(0.132M)とBoc−Trp−OH40.17g
(0.132M)を加え、次いで−15℃で冷却下、
WSC24.2ml(0.1321M)を滴下した後、室温で一
夜撹拌した。反応後、減圧後、減圧下DMFを留
去し、残渣を5%重曹水5に注ぎ、析出した生
成物を取した。これを水に懸濁して取した
後、メタノール−エーテルから2回再結晶して目
的物〔11〕を得た。 収量;142.57g(収率81.2%) 融点;168〜170℃ TLC;Rf1=0.31、Rf2=0.82 〔α〕28 D−18.64゜(C=1,DMF) 12) PF(23−28);Boc−Trp−Leu−Arg
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu−
OH〔12〕 化合物〔11〕140.64g(96.16mM)を熱エタノ
ール1200mlに溶解し、冷却後、少量の析出物を
別した後、1N−NaOH水溶液288ml(3倍M)を
加え、室温で1時間撹拌した。反応液に1N−
TosOH水溶液192ml(22倍M)を加えた後、別
し、エタノールを減圧下留去した。濃縮液に1N
−TosOH96ml(等M)を加え、次いで水2を
加えた後、生じた沈澱物を取した。水で2回洗
浄した後、乾燥して目的物〔12〕を得た。 収量;142.98g(収率101.1%) TLC;Rf2=0.71 融点;125〜130℃ 〔α〕27 D−37.24゜(C=1,DMF) 元素分析〔C69H94O15N12SCl2・2H2Oとして〕 C% H% N% 計算値 56.35 6.72 11.43 測定値 56.03 6.62 11.85 アミノ酸分析;Leu2(2)、Lys2.08(2)、Arg1.10
(1)、Trp0.83(1) 13) PF(23−34);Boc−Trp−Leu−Arg
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu−
Gln−Asp(OBzl)−Val−His−Asn−Tyr(Bzl
−Cl2)−NH2〔13〕 化合物〔6〕1.68g(1.5mM)を少量の塩化メ
チレンに懸濁し、次いで氷冷下TFA7mlを加えた
後、室温で30分間撹拌した。反応後、減圧下
TFAを留去し、残渣にエーテルを加え、析出し
た結晶を取、乾燥した。この結晶を乾燥
DMF30mlに溶かし、少量のNMMで中和した。
この溶液に化合物〔12〕2.43g(1.65mM)、
HOB;0.22g(1.65mM)および乾燥DMF20ml
を加え、次いで−15℃で冷却下WSC0.3ml(1.1倍
M)を加えた後、室温で一夜撹拌した。反応後、
減圧下DMFを留去し、残渣を5%重曹水で1回、
水で2回洗浄した後、メタノールに懸濁し、エー
テルを加え、取、乾燥して目的物〔13〕を得
た。 収量;3.62g(収率99.1%) 融点;260〜270℃ 〔α〕25 D−4.66゜(C=0.3,DMF) アミノ酸分析;Asp1.94(2)、GGlu0.96(1)、
Val0.71(1)、Leu2.00(2)、Tyr0.98(1)、Lys2.09(2)、
His0.58(1)、rg0.91(1)、Trp0.78(1) 114) PF(22);Boc−Glu(OBzl)−OPAC〔14〕 Boc−Glu(OBzl)−OH128.2g(0.38M)を
DMF600mlに溶かし、これに氷冷下フエナシル
ブロマイド113.5g(0.57M)を加えた後、
Et3N79.3ml(0.57M)を滴下した。滴下後、30
℃で4時間撹拌し、次いで酢酸カリウム30gを
加え、45分間撹拌した後、減圧下DMFを留去
した。残渣に酢酸エチル600mlを加え、5%重
曹水で2回、水で2回洗浄し、酢酸エチル層を
無水芒硝で乾燥後、減圧下溶媒を留去すると、
結晶が析出した、これにヘキサンを加え、取
して目的物〔14〕を得た。 収量;156.19g(収率90.2%) TLC;Rf5=0.73 15) PF(21−22);Boc−Val−Glu(OBzl)−
OPAC〔15〕 化合物〔14〕147.88g(0.325M)に塩化メチ
レン50mlを加え、これに氷冷下TFA300mlを加
え、室温で1時間撹拌した後、減圧下で塩化メチ
レンおよびTFAを留去した。残渣にエーテルを
加え、析出した結晶を取、乾燥した。この結晶
を乾燥DMF300mlに溶解し、NMMでPH7に中和
した。この溶液にHHOBt35.14g(0.26M)およ
びBoc−Val−OH56.49g(0.26M)を加え、−15
℃で冷却下WSC47.6ml(0.26M)を滴下した後、
室温で2日間撹拌した。反応後、減圧下でDMF
を留去し、残渣をクロロホルム500mlに溶かし、
5%重曹水、水、1N塩酸、水の順で洗浄した。
クロロホルム層を無水芒硝で乾燥し、減圧下溶媒
を留去し、得られた結晶にヘキサンを加えて取
した後、酢酸エチル−エーテルより再結晶化して
目的物〔15〕を得た。 収量;106.97g(収率74.2%) TLC;Rf3=0.63 融点;139〜141℃ 〔α〕29 D−18.92゜(C=1,DMF) 16) PF(20−22);Aoc−Ars(Tos)−Val−
Glu(OBzl)−OPAC〔16〕 化合物〔15〕99.83g(0.18M)に塩化メチレ
ン50mlを加え、これに氷冷下TFA200mlを加え、
室温で1時間撹拌した後、減圧下で塩化メチレン
およびTFAを留去した。残渣にヘキサンを加え
て処理し、傾斜法によりヘキサンを除去した後、
エーテルを加えて処理した後、減圧下でエーテル
を留去した。得られた油状物を乾燥DMF200mlに
溶かし、NMMで中和した。この溶液に
HOBt24.33g(0.18M)、Aoc−Arg(Tos)−
OH76.60g(0.18M)および乾燥DMF200mlを加
え、これに−15℃で冷却下WSC32.94ml(0.18M)
を滴下した後、室温で一夜撹拌した。反応後、減
圧下DMFを留去し、残渣を酢酸エチル1に溶
解した。この溶液を5%重曹水、水、1N塩酸、
水の順で洗浄し、無水芒硝で乾燥後、減圧下酢酸
エチルを留去した。得られた油状物を酢酸エチル
−エーテルより結晶化し、得られた結晶をエーテ
ルに懸濁して取する工程を3回行つて目的物
〔16〕を得た。 収量;149.75g(収率94.6%) TLC;Rf1=0.74、Rf4=0.81 融点;110〜114℃ 〔α〕29 D−11.5゜(C=1,DMF) 17) PF(19−22);Boc−Glu(OBzl)−Arg
(Tos)−Val−Glu(OBzl)−OPAC〔17〕 化合物〔16〕149.40g(0.170M)に塩化メチ
レン50mlを加え、これに氷冷下TFA300mlを加
え、室温で1時間撹拌した後、減圧下で塩化メチ
レンおよびTFAを留去した。残渣にエーテルを
加えて処理し、減圧下でエーテルを留去した後、
得られた油状物を乾燥DMF200mlに溶かした。こ
れにHOBt25.27g(0.187M)およびBoc−Glu
(OBzl)−OH63.09g(0.187M)を加え、乾燥
DMF100mlを追加し、−15℃で冷却下WSC34.22ml
(0.187M)を加え、室温で一夜撹拌した。反応
後、溶媒を留去し、残渣を水6l中に投ぎ込み、析
出した結晶を取した。この結晶をメタノールお
よびエーテルを加えて懸濁してて取し、熱メタ
ノールに溶かして、冷時に析出化して取し、さ
らにメタノールに懸濁して取する工程を3回行
つて化合物〔17〕を得た。結晶母液から溶媒を留
去し、メタノール−エーテルから結晶化して目的
物〔25.02gを得た。 収量;141.44g(収率76.7%) TLC;Rf1=0.56、Rf4=0.82 融点;119〜121℃ 〔α〕29 D−129゜(C=1,DMF) 18) PF(18−22);Boc−Nle−Glu(OBzl)−
Arg(Tos)−Val.Glu(OBzl)−OPAC〔18〕 化合物〔17〕6.51g(6mM)氷冷下塩化メチ
レンおよびTFA24mlを加え、室温で40分間撹拌
した後、減圧下塩化メチレンおよびTFAを留去
した。残渣にエーテルを加えて結晶化し、乾燥し
た。この結晶を乾燥DMFに溶かし、氷冷下
NMMでPH7に中和した。この溶液にBoc−Nle
−OH1.67g(7.2mM)およびHOBt0.97g
(7.2mM)を乾燥DMF40mlに溶解した溶液を加
え、−15℃に冷却下WSC1.3ml(7.2mM)を加え
た後、一夜撹拌した。反応後、減圧下DMFを留
去し、残渣に水を加え、生じた沈澱物を取し、
5%重曹水、水(3回)、1N塩酸水(3回)、メ
タノールの順で洗浄した。次いでメタノール−エ
ーテルから再沈澱を行ない、目的物〔18〕を得
た。 収量;5.61g(収率78%) TLC;Rf1=0.56 19) PF(18−22);Boc−Nle−Glu(OBzl)−
Arg(Toc)−Val−Glu(OBzl)−OH〔19〕 化合物〔18〕5.03g(4.2mM)を酢酸30mlに溶
かし、これに亜鉛末8gを加え、室温で5.5時間
撹拌した。反応後、亜鉛末を去し、減圧下酢酸
を留去した。析出した結晶にエーテルを加えて
取して目的物〔19〕を得た。 収量;4.42g TLC;Rf1=0.18、Rf2=0.67 融点;210℃(分解) アミノ酸分析;Nle1.01(1)、Glu2.05(2)、
Arg0.98(1)、Val/(1) 20) PF(18−34);Boc−Nle−Glu(OBzl)−
Arg(Tos)−Val−Glu(OBzl)−Trp−Len−
Arg(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu
−Gln−Asp(OBzl)−Val−His−Asn−Tyr
(Bzl−Cl2)−NH2〔20〕 化合物〔13〕8.9g(3.5mM)にスカトール0.5
g(3.5mM)、ジメチルスルフイド25ml、エタン
ジチオール2.5mlおよびTFA25mlを加え、0℃で
10分間、室温で45分間撹拌した後、反応液を減圧
濃縮した。残渣にエーテルを加え、生じた沈澱物
を取、乾燥した後、乾燥DMF100mlに溶かし、
NMMでPH7に中和した。この溶液にHOBt0.54
g(4mM)および化合物〔19〕4.3g(4mM)
を加え、−15℃に冷却下WSC0.73mlを加えた後、
室温で2日間撹拌した。反応後、減圧下DMFを
留去し、残渣に5%重曹水を加え、生じた沈澱物
を取した後、水で充分に洗浄した。この生成物
をエタノールに溶かし、エーテルを加えて沈澱化
させる工程を2回行つて目的物〔20〕を得た。 収量;11.12g(収率94%) TLC;Rf3=0.72 融点;250℃(分解) 〔α〕28 D−4.73゜(C=0.53、DMF) アミノ酸分析;Asp1.98(2)、Glu3.04(3)、
Val1.69(2)、Len2(2)、Tyr1.07(1)、Lys1.93(2)、
His0.59(1)、Arg1.97(2)、Trp0.35(1)、Nle1.07(1) 21) PF(17);Boc−Ser(Bzl)−OPAC〔21〕 Boc−Ser(Bzl)−OH88.6g(0.3M)を
DMF400mlに溶解し、これにフエナシルブロマイ
ド89.6g(0.45M)を加え、これに氷冷下
Et3N62.6ml(0.45M)を滴下した後、30℃で3.5
時間撹拌した。次いでこの反応液に酢酸カリウム
22.1g(0.225M)を加え、室温で1時間間撹拌
した。反応後、減圧下DMFを留去し、残渣を酢
酸エチル500mlに溶かし、5%重曹水、水の順で
洗浄した。酢酸エチル層を無水芒硝で乾燥した
後、減圧下溶媒を留去した。残渣を冷蔵庫に放置
して結晶化させ、ヘキサンをを加えて取して目
的物〔21〕を得た。 収量;122.97g(収率99.1%) TLC;Rf5=0.82 〔α〕29.5 D−11.88゜(C=1.0,DMF) 融点;45〜47℃ 22) PF(16−17);Boc−Asn−Ser(Bzl)−
OPAC〔22〕 化合物〔21〕119.9g(0.29M)に塩化メチレ
ン50mlを加え、これに氷冷下TFA250mlを加えた
後、室温で1時間撹拌した。反応後、減圧濃縮
し、残渣にエーテルを加え、析出した結晶を
取、乾燥した。この結晶を乾燥DMF400mlに溶か
し、NMMでPH7に中和した。この溶液に
HOBt31.35g(0.232M)およびBoc−Asn−
OH53.88g(0.232M)を加え、これに−15℃に冷
却下WSC42.46ml(0.232M)を滴下した後、室温
で一夜撹拌した。反応後、減圧下DMFを留去し、
残渣を酢酸エチル500mlに溶かし、5%重曹水で
洗浄した。分液の際、結晶が析出したので、その
結晶を取して水洗し、次いでエーテルで洗浄し
て目的物〔22〕の結晶41.79gを得た。液の
酢酸エチル層は、これを減圧濃縮し、残渣の油状
物を酢酸エチル−エーテルより結晶して目的物
〔22〕の結晶6.22gを得た。 収量;48.01g(収率39.2%) TLC;Rf2=0.61、Rf4=0.62 融点;174〜176℃ 〔α〕29.5 D−5.54゜(C=1.0,DMF) アミノ酸分析;Asp1.22(1)、Ser1.00(1) 23) PF(15〜17);Boc−Leu−Asu−Ser(Bzl)
−OPAC〔23〕 化合物〔22〕80.91g(0.153M)に塩化メチレ
ン50mlを加え、次いで氷冷下TFA150mlを加えた
後、室温で1時間撹拌した。反応液を減圧濃縮
し、残渣にエーテルを加え、生じた油状物を傾斜
法により分離した後、乾燥DMF150mlに溶かし、
NMMでPH7に中和した。この溶液HOBt22.7g
(0.168M)、Boc−Leu−OH・H2O41.9g
(0.168M)およびDMF100mlを加え、−15℃に冷
却下WSC30.7ml(0.168M)を滴下した後、室温
で撹拌した反応液がゲル化したので、氷室に3日
間静置した後、水を加え、生じた沈澱物を取
し、5%重曹水、水の順で洗浄、乾燥して目的物
〔23〕を得た。 収量;88.52g(収率90.3%) TLC;Rf2=0.80、Rf3=0.88 融点;192〜193℃ 元素分析〔C33H44O9N4として〕 C% H% N% 計算値 61.86 6.92 8.75 測定値 61.81 7.05 8.56 24) PF(14−17);Boc−His(Tos)−Leu−
Asn−Ser(Bzl)−OPAC〔24〕 化合物〔28〕87.55g(0.137M)に塩化メチレ
ン100mlを加え、次いで氷冷下TFA200mlを加え
た後、室温で70分間撹拌した。反応液を減圧濃縮
し、残渣にエーテルを加え、生じた沈澱物を
取、乾燥した後、乾燥DMF200mlに溶かし、
NMMでPH7に中和して脱Boc溶液を得た。 一方、Boc−His(Tos)−OH・DCHA89.2g
(0.151M)を酢酸エチル1に懸濁し、1N硫酸
500mlで洗浄し、析出した結晶を別した。酢酸
エチル層を水洗し、無水芒硝で乾燥した後、減圧
下溶媒を留去した。得られた油状物を乾燥
DMF150mlに溶解した溶液とHOBt20.4g
(0.151M)を前記の脱Boc溶液に加え、これに−
15℃に冷却下WSC27.6ml(0.151M)を滴下した
後、室温で3日間撹拌した。反応後、減圧下溶媒
を留去し、残渣を水に加え、生じた沈澱物を取
した後、5%重曹水、水の順で洗浄し、乾燥して
目的物〔24〕を得た。 収量;108.63g(収率85.51%) TLC;Rf2=0.20、0.79 Rf=0.55、0.87 一部Tosが脱離したものが得られた。 融点;154〜156℃ 〔α〕29.5 D−18.58゜(C=1.0,DMF) 25) PF(13〜17);Boc−Lys(Z−Cl)−His−
Leu−Asn−Ser(Bzl)−OPAC〔25〕 化合物〔24〕107.96g(0.1161M)に塩化メチ
レン100mlを加え、次いで氷冷下TFA200mlを加
えた後、室温で70分間撹拌した。反応液を減圧濃
縮し、残渣にエーテルを加え、生じた沈澱物を
取、乾燥後、乾燥DMF200mlに溶かし、NMMで
PH7に中和して脱Boc溶液を得た。 一方、Boc−Lys(Z−Cl)−OH・TBA62.46g
(0.128M)を酢酸エチル600mlに懸濁し、1N塩
酸、水の順に洗浄し、酢酸エチル層を無水芒硝で
乾燥後、減圧下溶媒を留去した。得られた油状物
とHOBt17.30g(0.128M)を乾燥DMF100mlに
溶かした溶液を前記の脱Boc溶液に加え、これに
−15℃に冷却下WSC24.42ml(0.128M)を滴下し
た後、室温で一夜撹拌した。反応後、減圧下溶媒
を留去し残渣を3%重曹水5中に加え、析出し
た結晶を充分に水洗した後、乾燥した。この結果
をメタノールに溶かし、エーテルを加えて沈澱化
させた。得られた沈澱物を酢酸エチルに懸濁し、
取する工程を3回行つて目的物〔25〕を得た。 収量;114.42g(収率91.8%) TLC;Rf2=0.34、Rf3=0.68 融点;200〜202℃ 〔α〕28 D−26.94゜(C=1.0,DMF) 26) PF(13−17);Boc−Lys(Z−Cl)−His−
Leu−Asn−Ser(Bzl)−OH〔26〕 化合物〔25〕86.0g(80mM)を酢酸500mlに
溶かし、これに亜鉛末150gを加え、室温で5時
間撹拌した後、反応液を過して亜鉛末を除去し
た。反応液を減圧濃縮し、残渣にエーテルを加
え、析出した結晶を取して目的物〔26〕を得
た。 収量;84.70g(収率95.2%) TLC;Rf2=0.47 融点;240〜250℃ 〔α〕30 D−19.16゜(C=1.0,DMF) 元素分析〔C45H52O12N9Cl・2CH3COOH・
2H2Oとして〕 C% H% N% 計算値 53.76 6.63 11.52 測定値 52.83 6.36 11.35 アミノ酸分析;Asp1.01(1)、Ser0.83(1)、Leu/
(1)、Lys0.93(1)、His0.97(1) 27) PF(13−34);Boc−Lys(Z−Cl)−His−
Leu−Asn−Ser(Bzl)−Nle−Glu(OBzl)−
Arg(Tos)−Val−Glu(OBzl)−TrP−Leu−
Arg(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu
−Gln−Asp(OBzl)−Val−His−Asn−Tyr
(Bzl−Cl2)−NH2〔27〕 化合物〔20〕10.77g(3.2mM)にスカトール
0.46g(3.2mM)、ジメチルスルフイド25ml、エ
タンジチオール2.5mlおよびTFA25mlを加え、0
℃で10分間、室温で60分間撹拌した後、反応液を
減圧濃縮した。残渣にエーテルを加え、生じた沈
澱物を取、乾燥した後、乾燥DMF100mlに溶か
し、NMMでPH7に中和した。次いでこれに
HOBt0.51g(3.8mM)および化合物〔26〕4.23
g(3.8mM)を加え、−15℃に冷却下WSC0.70ml
を加えた後、室温で一夜撹拌した。反応後、減圧
下DMFを留去し、残渣に水を加え、生じた沈澱
物を取し、水洗、乾燥して目的物〔27〕を得
た。 収量;13.60g(収率100%) 融点;138〜160.5℃ 〔α〕28 D−19.6゜(C=0.56,DMF) アミノ酸分析;Asp2.96(3)、Ser0.62(1)、
Glu3.02(3)、Val1.72(2)、Leu3(3)、Tyr1.06(1)、
Lys3.01(3)、His1.43(2)、Arg1.98(2)、Trp0.60(1)、
Nle1.06(1)、 28) PF(11−12);Boc−Leu−Gly−OBzl〔28〕 Boc−Leu−OH・H2O4.99g(20mM)を乾燥
THF30mlに溶かし、これに乾燥ベンゼン50mlを
加え、溶媒を共弗により留去した。得られた油状
物を乾燥THF70mlに溶かし、これにH−Gly−
OBzl・TosOH(20mM)およびHOBt2.7g
(20mM)を加え、次いで一5℃に冷却下WSC5
mlを加えた後、室温で一夜撹拌した。反応後、減
圧下溶媒を留去し、残渣を酢酸エチル100mlに溶
かした後、1N塩酸で2回、5%重曹水で2回、
水で2回の順で洗浄した。酢酸エチル層を無水芒
硝で乾燥した後、減圧濃縮して油状の目的物
〔28〕を得た。 29) PF(10−12);Boc−Asn−Leu−Gly−
OBzl〔29〕 前記で得た油状物〔28〕に−15℃に冷却下
4.39N塩化水素/ジオキサン溶液40mlを加え、90
分間撹拌した後、減圧濃縮した。残渣にエーテル
を加え、生じた沈澱物を取、乾燥した後、乾燥
DMF30mlに溶かした。これに−5℃に冷却下
Et3Nを加えてPH7に調節し、次いでHOBt0.3g
(2.2mM)およびBoc−Asn−ONP7.77g
(22mM)を加え、室温で3日間撹拌した。反応
液に水を加え、析出した沈澱物をクロロホルム
200mlで抽出した。クロロホルム層を1N塩酸、5
%重曹水、水の順で洗浄し、無水芒硝で乾燥後、
減圧下溶媒を留去した、残渣を酢酸エチル−ヘキ
サンから結晶化して目的物〔29〕を得た。 収量;8.0g(収率73.8%) 融点;152−156℃ 〔α〕24 D−36.1゜(C=1.0,DMF) 30) PF(9−12);Boc−His−Asn−Leu−
Gly−OBzl〔30〕 化合物〔29〕7.36g(15.5mM)に塩化メチレ
ン5mlを加え、次いで氷冷下TFA32mlを加えた
後、室温で60分間撹拌した。反応液を減圧濃縮
し、残渣にエーテルを加え、析出した沈澱物を
取、乾燥した後、乾燥DMF40mlに溶かし、
NMMでPH7に調節して脱Boc溶液を得た。 一方、Boc−His(Tos)−OH・DCHA10.99g
(18.6mM)に酢酸エチル150mlおよび0.5N硫酸90
mlを加えて振とうし、酢酸エチル層を水で3回洗
浄し、無水芒硝で乾燥後、酢酸エチルを減圧下留
去して油状物を得た。この油状物とHOBt2.5g
(18.6mM)を乾燥DMF60mlに溶かし、その溶液
を前記の脱Boc溶液に加え、次いで−15℃に冷却
下WSC3.4ml(18.6mM)を加えた後、室温で一
夜撹拌した。反応後、減圧下溶媒を留去し、残渣
を酢酸エチルに溶かし、5%重曹水で3回、水で
2回洗浄し、無水芒硝で乾燥後、減圧下溶媒を留
去した。残渣にエーテルを加え、析出した結晶を
取した。この結晶はHisのTosが一部脱離され
ているが、完全に脱離するために、この結晶を
DMF100mlに溶解し、これにHOBt7.05gを加え、
室温で3日間撹拌した。反応後、減圧下DMFを
留去し、残渣を酢酸エチルに溶かし、5%重曹水
で2回、水の順に洗浄し、無水芒硝で乾燥後、減
圧下溶媒を留去した。析出した結晶にエーテルを
加えて取して目的物〔30〕を得た。 収量;7.32g(収率74.8%) TLC;Rf2=0.1 31) PF(8−12);Boc−Nle−His−Asn−
Leu−Gly−OBzl〔31〕 化合物〔30〕7.32g(11.6mM)に塩化メチレ
ン5mlを加え、次いで氷冷下TFA30mlを加えた
後、室温で40分間撹拌した。反応液を減圧濃縮
し、残渣にエーテルを加え、析出した沈澱物を
取、乾燥した後、乾燥DMF40mlに溶かし、
NMMでPH7に調節した。これにHOBt1.9g
(13.92mM)およびBoc−Hle−OH3.23g
(13.92mM)を乾燥DMFに溶かした溶液を加え、
−15℃に冷却下WSC2.5ml(13.92mM)を加えた
後、室温で一夜撹拌した。反応後、減圧下溶媒を
留去し、残渣に水を加え、析出した沈澱物を取
し、5%重曹水で2回、1N塩酸で2回、水で3
回の順で洗浄し、乾燥して目的物〔31〕を得た。 収量;3.70g(収率42.9%) TLC;Rf2=0.20 32) PF(8−12);Boc−Nle−His−Asn−
Leu−Gly−OH〔32〕 化合物〔31〕2.8g(3.8mM)をエタノール100
mlに溶かし、これに10%Pd/C300mgを加え、室
温で水素ガスを3時間通じた。反応液中に不溶物
が析出したので、過し、DMFで洗浄した後、
液を減圧濃縮した。残渣にエタノール−エーテ
ルを加えて沈澱物を取、乾燥して目的物〔32〕
を得た。 収量;1.76g(収率71.1%) 融点;112.5℃ TLC;Rf2=0.05 アミノ酸分析;Asp0.96(1)、Gly0.98(1)、Leu/
(1)、His0.95(1)、Nle0.94(1) 33) PF(8−34);Boc−Nle−His−Asn−
Leu−Gly−Lys(Z−Cl)−His−Leu−Asn−
Ser(Bzl)−Nle−Glu(OBzl)−Arg(Tos)−
Val−Glu(OBzl)−TrP−Leu−−Arg(Tos)−
Lys(Z−Cl)−Lys(Z−Cl)−Leu−Gln−AsP
(OBzl)−Val−His−Asn−Tyr(Bzl−Cl2)−
NH2〔33〕 化合物〔27〕10.60g(2.5mM)のスカトール
0.33g(2.5mM)、ジメチルスルフイド25ml、エ
タンジチオール2.5mlおよびTFA25mlを加え、0
℃で10分、室温で50分間撹拌した後、反応液を減
圧濃縮した。残渣にエーテルを加え、生じた沈澱
物を取、乾燥した後、乾燥DMF100mlに溶か
し、これに氷冷下NMMを加えてPH7に調節し
た。この溶液にHOBt0.36g(2.7mM)および化
合物〔32〕1.76g(2.7mM)を加え、−15℃に冷
却下WSC0.5mlを加えた後、室温で一夜撹拌し
た。析出した沈澱物を取し、水で洗浄、乾燥し
た後、エタノール−エーテルから再沈澱して目的
物〔33〕を得た。 収量;10.94gへ(収率91.7%) 融点;140.5〜162℃ 〔α〕28 D−1.94゜(C=0.52,DMF) アミノ酸分析;Asp3.87(4)、Ser0.76(1)、
Glu3.34(3)、Gly0.77(1)、Val1.84(2)、Leu4(4)、
Tyr1.04(1)、Lys3.28(3)、His2.37(3)、Ars2.14(2)、
Trp0.73(1)、Nle2.07(2) 34)) PF(7);Boc−Leu−OPAC〔34〕Boc−
Leu−OH・H2O15.0g(60mM)とフエナシ
ルブロマイド17.9g(90mM)をDMF100mlに
溶かし、これに氷冷下Et3N12.5ml(90mM)を
滴下した後、30℃で2時間撹拌した。次いで酢
酸カリウム4.42g(45mM)を加え、室温で45
分間撹拌した後、減圧下DMFを留去した。残
渣を酢酸エチルに溶かし、5%重曹水で2回、
水で2回洗浄し、酢酸エチル層を無水芒硝で乾
燥後、減圧下溶媒を留去した。残渣を氷室に放
置し、析出した結晶を乾燥して目的物〔34〕を
得た。 収量;21.23g(収率100%) TLC;Rf1=0.89 35) PF(6−7);Boc−Gln−Leu−OPAC
(35〕 化合物〔34〕20.96g(60mM)に塩化メチレ
ン20mlを加え、次いで氷冷下TFA80mlを加え、
室温で40分間撹拌した後、反応液を減圧濃縮し
た。残渣にエーテルを加え、生じた沈澱物を
取;乾燥した後、乾燥DMF70mlに溶かし、氷冷
下NMMを加えてPH7に調節した。この溶液に
HOBt8.1g(60mM)およびBoc−Gln−
OH14.78g(60mM)を乾燥DMF90mlに溶かし
た溶液を加え、−15℃に冷却下WSC10.9ml
(60mM)を滴下した後、室温で一夜撹拌した。
反応後、DMFを減圧留去し、残渣を酢酸エチル
に溶かした後、5%重曹水で2回、1N塩酸で2
回、水で3回の順で洗浄した。酢酸エチル層を無
水芒硝で乾燥し、減圧下溶媒を留去した後、析出
した結晶にヘキサンを加えて取、乾燥して目的
物(35〕を得た。 収量;17.25g(収率60.2%) TLC;Rf1=0.38 36) PF(5−7);Boc−Ile−Gln−Leu−
OPAC〔36〕 化合物〔35〕17.19g(36mM)に塩化メチレ
ン10mlを加え、次いで氷冷下TFA70mlを加え、
室温で60分間撹拌した後、反応液を減圧濃縮し
た。残渣を減圧乾燥後、乾燥DMF130mlに溶か
し、氷冷下NMMでPH7に調節した。この溶液に
HOBt5.3g(39.6mM)およびBoc−Ile−OH・
1/2H2O9.5g(39.6mM)を乾燥DMF70mlに溶か
した溶液を加え、−15℃に冷却下WSC7.2ml
(39.6mM)を滴下した後、室温で一夜撹拌した。
反応後、DMFを減圧留去し、残渣に5%重曹水
を加え、生じた沈澱物を取した後、5%重曹
水、1N塩酸で2回、水で3回の順で洗浄し、乾
燥した。この沈澱物をエタノール−エーテルから
再沈澱化して目的物〔36〕を得た。 収量;16.35g(収率76.9%) TLC;Rf1=0.41、Rf2=0.68 37) PF(4−7);Boc−Glu(OBzl)−Ile−Gln
−Leu−OPAC〔37〕 化合物〔36〕16.24g(27.5mM)を塩化メチレ
ン10mlを加え、次いで氷冷下TFA70mlを加え、
次いで氷冷下TFA70mlを加え、室温で60分間撹
拌した後、反応液を減圧濃縮した。残渣にエーテ
ルを加え、生じた沈澱物を取、乾燥した後、乾
燥DMF100mlに溶かし、次いで氷冷下NMMを加
えてPH7に調節した。この溶液にHOBt4.09g
(30.25mM)およびBoc−Glu(OBzl)−OH10.2g
(30.25mM)を乾燥DMF50mlに溶かした溶液を
加え、−15℃に冷却下WSC5.5mlを滴下した後、
室温で一夜撹拌した。反応後、DMFを減圧留去
し、残渣に5%重曹水を加えて生じた沈澱物を
取した後、5%重曹水、1N塩酸で2回、水で4
回の順で洗浄、乾燥した。エタノール−エーテル
から再沈澱して目的物〔37〕を得た。 収量;21.68g(収率97.1%) TLC;Rf=0.52 38) PF(3−7);Boc−Ser(Bzl)−Glu
(OBzl)−Ile−Gln−Leu−OPAC〔38〕 化合物〔37〕21.46g(26.5mM)に塩化メチレ
ン10mlを加え、次いで氷冷下TFA90mlを加え、
室温で1時間撹拌した後、反応液を減圧濃縮し
た。残渣にエーテルを加えて、生じた沈澱物を
取、乾燥した後、乾燥DMF150mlに溶解し、次い
で氷冷下NMMを加えてPH7に調節した。この溶
液にHOBt3.9g(29.15mM)およびBoc−Ser
(Bzl)−OH8.6g(29.15mM)を乾燥DMF50ml
に溶かした溶液を加え、−15℃に冷却下WSC5.3
ml(29.15mM)を加えた後、室温で一夜撹拌し
た。反応後、DMFを減圧留去し、残渣に5%重
曹水を加え、析出した沈澱物を取した。これを
5%重曹水、1N塩酸で2回、水で4回の順で洗
浄した後、エーテルに懸濁、取して目的物
〔38〕を得た。 収量;24.8g(収率94.7%) TLC;Rf1=0.53 39) PF(2−7);Boc−Val−Ser(Bzl)−Glu
(OBzl)−Ile−Gln−Leu−OPAC〔39〕 化合物〔38〕24.68g(25mM)に塩化メチレ
ン20mlを加え、次いで氷冷TFA100mlを加えた
後、室温で50分間撹拌した。反応液を減圧濃縮
し、残渣にエーテルを加え、生じた沈澱物を
取、乾燥した後、乾燥DMF120mlに溶かし、次い
で氷冷下NMMを加えてPH7に調節した。この溶
液にHOBt4.05g(30mM)およびBoc−Val−
OH6.5g(30mM)を乾燥DMF80mlに溶かした
溶液を加え、−15℃に冷却下WSC5.5ml(30mM)
を滴下した後、室温で一夜撹拌した。反応液に沈
澱物が析出したので、水を加えて取し、5%重
曹水で2回、1N塩酸で2回、水で4回の順で洗
浄した後、エーテルに懸濁、取して目的物
〔39〕を得た。 収量;26.32g(収率96.8%) TLC;Rf1=0.49 40) PF(1−7);Boc−Ser(Bzl)−Val−Ser
(Bzl)−Glu(OBzl)−Ile−Gln−Leu−OPAC
〔40〕 化合物〔39〕26.07g(24mM)に塩化メチレ
ン20mlを加え、次いで氷冷下TFA100mlを加えた
後、室温で40分間撹拌した。反応液を減圧濃縮
し、残渣にエーテルを加え、生じた沈澱物を
取、乾燥した後、乾燥DMF100mlに溶かし、次い
で氷冷下NMMを加えてPH7に調節した。この溶
液にHOBt3.9g(28.8mM)およびBoc−Ser
(Bzl)−OH8.5g(28.8mM)を乾燥DMF50mlに
溶かした溶液を加え、−15℃に冷却下WSC5.3ml
(28.8mM)を添加した後、室温で一夜撹拌した。
反応液に沈澱物が析出したので、水を加えて取
し、5%重曹水、1N塩酸、水の順で洗浄した後、
エーテルに懸濁し、取する工程を2回行つて目
的物〔40〕を得た。 収量;28.0g(収率92.3%) TLC;Rf1=0.53 41) PF(1−7);Boc−Ser(Bzl)−Val−Ser
(Bzl)−Glu(OBzl)−Ile−Gln−Leu−OH〔41〕 化合物〔40〕12.6g(10mM)を酢酸300mlに
溶かし、これに亜鉛末15gを加え、50℃で4時間
撹拌した後、亜鉛末を別した。酢酸を減圧留去
し、残渣にエーテルを加え、析出した結晶を
取、洗浄して目的物〔41〕を得た。 収量;11.15g(収率97.4%) 融点;260℃(分解) TLC;Rf1=0.14、Rf2=0.64 アミノ酸分析;Ser1.81(2)、Glu2.02(2)、
Val0.95(1)、Leu1(1)、Ile0.92(1) 42) 保護−〔Nle8,Nle18,Tyr34〕−h−PTH
(1−34)NH2;Boc−Ser(Bzl)−Val−Ser
(Bzl)−Glu(OBzl)−Ile−Gln−Leu−Nls−
His−Asn−Leu−Gly−Lys(Z−Cl)−His−
Leu−Asn−Ser(Bzl)−Nle−Glu(OBzl)−
Arg(Tos)−Val−Glu(OBzl)−Trp−Leu−
Arg(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu
−Gln−Asp(OBzl)−Val−His−Asn−Tyr
(Bzl)−Cl2)−NH2〔42〕 化合物〔33〕10.86g(2.28mM)に氷冷下スカ
トール0.30g(2.28mM)、ジメチルスルフイド25
ml、エタンジチオール2.5mlおよびTFA25mlを加
え、室温で60分間撹拌した後、減圧濃縮した。残
渣にエーテルを加え、生じた沈澱物を取、乾燥
した後、乾燥DMF100ml+DMSO10mlの混液に
溶かし、次いで氷冷下NMMを加えてPH7に調節
した。この溶液にHOBt0.37g(2.74mM)およ
び化合物〔41〕3.14g(2.74mM)を加え、次い
で−15℃に冷却下WSC0.50ml(2.74mM)を加え
た後、室温で一夜撹拌した。反応液に水を加え、
生じた沈澱物を取し、充分に水洗した後、エタ
ノール−エーテルで洗浄して目的物〔42〕を得
た。 収量;12.87g(収率97.3%) 融点;139.5〜175℃ 〔α〕28 D−1.97゜(C=0.51,DMF) アミノ酸分析;Asp3.72(4)、Ser2.76(3)、
Glu5.58(5)、Gly0.69(1)、Val2.86(3)、Ile1.11(1)、
Leu5(5)、Tyr0.99(1)、Lys2.87(3)、His2.19(3)、
Arg2.06(2)、Trp0.65(1)、Nle1.96(2) 43) 〔Nle8,Nle18,Tyr34〕−h−PTH(1−
34)NH2 化合物〔42〕2.9g(0.5mM)に0℃に冷却下
アニソール3.5ml、エタンジチオール0.35ml、ジ
メチルスルフイド3.5mlおよび無水HF35mlを加
え、60分間撹拌した。反応後、HFを減圧下留去
し、残渣にエーテルを加え、生じた沈澱物を集め
た後、0.1N酢酸に溶解した。この溶液をダウエ
ツクス×1(アセテート型)のカラム(3.5×12
cm)に通し、ニンヒドリン陽性のフラクシヨンの
みを集めて凍結乾燥して粗生成物1.87gを得た。
これを0.1N酢酸50mlに溶かし、CM−セルロース
のカラム(2×33cm)にチヤージし、0.05M酢酸
アンモニウム(PH5.1)1〜0.4M酢酸アンモニ
ウム(PH6.0)1の直線型濃度勾配による溶出
を行つた。各フラクシヨンは9.0mlづつ分画し、
TLCによりRf6=0.30付近にスポツトを有する74
〜84本目のフラクシヨンを集め凍結乾燥した。こ
れを出来るだけ少量の0.1N塩酸に溶かし、この
溶液をセフアデツクスG−25のカラム(3×115
cm)にチヤージし、0.1N酢酸で溶出した。各フ
ラクシヨンはUV280nmにおける吸光度を測定
し、1つの大きなピークを有するフラクシヨンの
みを集めて凍結乾燥して〔Nle8,Nle18,Tyr34
−h−PTH(1−34)NH2を得た。 収量;140mg TLC;Rf6=0.30 アミノ酸分析(3%チオグリコール酸含有6N
塩酸で加水分解);Asp3.98(4)、Ser2.10(3)、
Glu4.93(5)、Gly0.97(1)、Val2.66(3)、Ile0.87(1)、
Leu5.00(5)、Tyr1.11(1)、Lys3.26(3)、His2.30(3)、
Arg2.03(2)、Trp0.62(1)、Nle2.22(2) 高速液体クロマトグラフイー; カラム;Nucleosil5C18(4nmID×150mm) 緩衝液;0.1Mリン酸含有0.1%酢酸−アセトニ
トリル(アセトニトリルの比率は最初の5分間は
20%、その後の20分間は20%〜40%の直線型濃度
勾配による) 流速;1ml/分 検出;225nm 測定結果;19.07分にのみピーク検出。
[9] Add 100 ml of methylene chloride and 250 ml of TFA to 217.9 g (0.185 M), stir at room temperature for 80 minutes, and then add methylene chloride and TFA under reduced pressure.
was removed. The resulting oil was dissolved in 300 ml of dry DMF and neutralized by adding NMM. in this solution
Boc−Leu−OH・H 2 O50.9g (0.204M) and
A solution of 27.6g (0.204M) of HOBt dissolved in 100ml of dry DMF was added and then cooled at -15°C.WSC37.3
ml (0.204M) was added dropwise, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, and the residue was added to water to collect the precipitated product. Methanol-
The desired product [10] was obtained by crystallization twice from ether-hexane. Yield: 213.63g (yield 90.5%) Melting point: 157-160℃ TLC; Rf 1 = 0.28, Rf 2 = 0.77 [α] 27 D −18.68° (C = 1, DMF) 11) PF (23−28) ;Boc−TrP−Leu−Arg
(Tos)−Lys(Z−Cl)−Lys:(Z−Cl)−Leu−
OEt [11] To 153.17 g (0.12 M) of compound [10] were added 100 ml of methylene chloride and 250 ml of TFFA, and after stirring at room temperature for 80 minutes, methylene chloride and TFA were distilled off under reduced pressure. Dissolve the residue in 250ml of dry DMF,
Neutralized to PH7 with NMM. HOBt17.84 in this solution
g (0.132M) and Boc−Trp−OH40.17g
(0.132M) and then cooled at -15℃.
After 24.2 ml (0.1321 M) of WSC was added dropwise, the mixture was stirred at room temperature overnight. After the reaction and after reducing the pressure, DMF was distilled off under reduced pressure, and the residue was poured into 5% aqueous sodium bicarbonate solution to collect the precipitated product. This was suspended in water and recrystallized twice from methanol-ether to obtain the desired product [11]. Yield: 142.57g (yield 81.2%) Melting point: 168-170℃ TLC; Rf 1 = 0.31, Rf 2 = 0.82 [α] 28 D −18.64° (C = 1, DMF) 12) PF (23−28) ;Boc−Trp−Leu−Arg
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu−
OH[12] Compound [11] 140.64g (96.16mM) was dissolved in 1200ml of hot ethanol, cooled, a small amount of precipitate was separated, 288ml of 1N-NaOH aqueous solution (3xM) was added, and the solution was dissolved at room temperature for 140.64g (96.16mM). Stir for hours. 1N− to the reaction solution
After adding 192 ml of TosOH aqueous solution (22 times M), the mixture was separated and ethanol was distilled off under reduced pressure. 1N in concentrate
- After adding 96 ml (equal M) of TosOH and then 2 portions of water, the resulting precipitate was collected. After washing twice with water, the product was dried to obtain the desired product [12]. Yield: 142.98g (yield 101.1%) TLC: Rf 2 = 0.71 Melting point: 125-130°C [α] 27 D −37.24° (C = 1, DMF) Elemental analysis [C 69 H 94 O 15 N 12 SCl 2・As 2H 2 O] C% H% N% Calculated value 56.35 6.72 11.43 Measured value 56.03 6.62 11.85 Amino acid analysis; Leu2(2), Lys2.08(2), Arg1.10
(1), Trp0.83(1) 13) PF (23−34); Boc−Trp−Leu−Arg
(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu−
Gln−Asp(OBzl)−Val−His−Asn−Tyr(Bzl
-Cl2 ) -NH2 [13] 1.68g (1.5mM) of compound [6] was suspended in a small amount of methylene chloride, and then 7ml of TFA was added under ice-cooling, followed by stirring at room temperature for 30 minutes. After reaction, under reduced pressure
TFA was distilled off, ether was added to the residue, and the precipitated crystals were collected and dried. Dry this crystal
It was dissolved in 30 ml of DMF and neutralized with a small amount of NMM.
In this solution, 2.43g (1.65mM) of compound [12],
HOB; 0.22g (1.65mM) and dry DMF 20ml
was added, and then 0.3 ml of WSC (1.1 times M) was added while cooling at -15°C, followed by stirring at room temperature overnight. After the reaction,
DMF was distilled off under reduced pressure, and the residue was diluted once with 5% sodium bicarbonate solution.
After washing twice with water, it was suspended in methanol, ether was added, and the mixture was taken and dried to obtain the desired product [13]. Yield: 3.62g (yield 99.1%) Melting point: 260-270℃ [α] 25 D -4.66゜ (C=0.3, DMF) Amino acid analysis: Asp1.94(2), GGlu0.96(1),
Val0.71(1), Leu2.00(2), Tyr0.98(1), Lys2.09(2),
His0.58(1), rg0.91(1), Trp0.78(1) 114) PF(22); Boc-Glu(OBzl)-OPAC[14] Boc-Glu(OBzl)-OH128.2g(0.38 M)
After dissolving in 600ml of DMF and adding 113.5g (0.57M) of phenacyl bromide under ice-cooling,
79.3 ml (0.57 M) of Et 3 N was added dropwise. After dripping, 30
The mixture was stirred at ℃ for 4 hours, then 30 g of potassium acetate was added, and after stirring for 45 minutes, DMF was distilled off under reduced pressure. Add 600 ml of ethyl acetate to the residue, wash twice with 5% aqueous sodium bicarbonate and twice with water, dry the ethyl acetate layer over anhydrous sodium sulfate, and then evaporate the solvent under reduced pressure.
Crystals were precipitated, and hexane was added thereto to obtain the desired product [14]. Yield: 156.19g (yield 90.2%) TLC; Rf 5 = 0.73 15) PF (21−22); Boc−Val−Glu(OBzl)−
OPAC [15] 50 ml of methylene chloride was added to 147.88 g (0.325 M) of compound [14], and 300 ml of TFA was added thereto under ice cooling. After stirring at room temperature for 1 hour, methylene chloride and TFA were distilled off under reduced pressure. Ether was added to the residue, and the precipitated crystals were collected and dried. The crystals were dissolved in 300 ml of dry DMF and neutralized to pH 7 with NMM. Add 35.14 g (0.26 M) of HHOBt and 56.49 g (0.26 M) of Boc-Val-OH to this solution, and -15
After dropping WSC47.6ml (0.26M) under cooling at °C,
Stirred at room temperature for 2 days. After reaction, DMF under reduced pressure
was distilled off, the residue was dissolved in 500 ml of chloroform,
It was washed in the following order: 5% sodium bicarbonate solution, water, 1N hydrochloric acid, and water.
The chloroform layer was dried over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure, hexane was added to the obtained crystals, and the crystals were recrystallized from ethyl acetate-ether to obtain the desired product [15]. Yield: 106.97g (yield 74.2%) TLC: Rf 3 = 0.63 Melting point: 139-141°C [α] 29 D -18.92° (C = 1, DMF) 16) PF (20-22); Aoc-Ars ( Tos)−Val−
Glu(OBzl)-OPAC [16] Add 50 ml of methylene chloride to 99.83 g (0.18 M) of compound [15], add 200 ml of TFA under ice cooling,
After stirring at room temperature for 1 hour, methylene chloride and TFA were distilled off under reduced pressure. After treating the residue with hexane and removing the hexane by decanting,
After treatment with ether, the ether was distilled off under reduced pressure. The resulting oil was dissolved in 200 ml of dry DMF and neutralized with NMM. In this solution
HOBt24.33g (0.18M), Aoc−Arg(Tos)−
Add 76.60 g of OH (0.18 M) and 200 ml of dry DMF, and add 32.94 ml of WSC (0.18 M) while cooling at -15°C.
was added dropwise, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate. This solution was mixed with 5% sodium bicarbonate, water, 1N hydrochloric acid,
After washing with water and drying with anhydrous sodium sulfate, ethyl acetate was distilled off under reduced pressure. The process of crystallizing the obtained oil from ethyl acetate-ether and suspending the obtained crystals in ether was performed three times to obtain the desired product [16]. Yield: 149.75g (yield 94.6%) TLC: Rf 1 = 0.74, Rf 4 = 0.81 Melting point: 110-114°C [α] 29 D −11.5° (C = 1, DMF) 17) PF (19-22) ;Boc−Glu(OBzl)−Arg
(Tos)-Val-Glu(OBzl)-OPAC [17] Add 50 ml of methylene chloride to 149.40 g (0.170 M) of compound [16], add 300 ml of TFA under ice cooling, stir at room temperature for 1 hour, and then reduce the pressure. Methylene chloride and TFA were distilled off at the bottom. The residue was treated with ether and the ether was distilled off under reduced pressure.
The resulting oil was dissolved in 200 ml of dry DMF. To this, HOBt25.27g (0.187M) and Boc-Glu
Add (OBzl)-OH63.09g (0.187M) and dry.
Add 100ml of DMF and 34.22ml of WSC under cooling at -15℃
(0.187M) and stirred at room temperature overnight. After the reaction, the solvent was distilled off, the residue was poured into 6 liters of water, and the precipitated crystals were collected. These crystals were suspended in methanol and ether, collected, dissolved in hot methanol, precipitated when cooled, and further suspended in methanol to be collected. These steps were repeated three times to obtain compound [17]. Ta. The solvent was distilled off from the crystal mother liquor, and the desired product (25.02 g) was obtained by crystallization from methanol-ether. Yield: 141.44g (yield 76.7%) TLC: Rf 1 = 0.56, Rf 4 = 0.82 Melting point: 119-121°C [α] 29 D −129° (C = 1, DMF) 18) PF (18-22) ;Boc−Nle−Glu(OBzl)−
Arg(Tos)-Val.Glu(OBzl)-OPAC [18] Compound [17] 6.51g (6mM) Methylene chloride and TFA 24ml were added under ice cooling, and after stirring at room temperature for 40 minutes, methylene chloride and TFA were added under reduced pressure. Distilled away. The residue was crystallized by adding ether and dried. Dissolve the crystals in dry DMF and cool on ice.
Neutralized to PH7 with NMM. In this solution, Boc−Nle
−OH1.67g (7.2mM) and HOBt0.97g
(7.2mM) dissolved in 40ml of dry DMF was added, and after cooling to -15°C, 1.3ml (7.2mM) of WSC was added thereto, followed by stirring overnight. After the reaction, DMF was distilled off under reduced pressure, water was added to the residue, and the resulting precipitate was collected.
Washing was performed in the following order: 5% sodium bicarbonate solution, water (3 times), 1N hydrochloric acid solution (3 times), and methanol. Next, reprecipitation was performed from methanol-ether to obtain the desired product [18]. Yield: 5.61g (yield 78%) TLC; Rf 1 = 0.56 19) PF (18−22); Boc−Nle−Glu(OBzl)−
Arg(Toc)-Val-Glu(OBzl)-OH [19] Compound [18] 5.03 g (4.2 mM) was dissolved in 30 ml of acetic acid, 8 g of zinc powder was added thereto, and the mixture was stirred at room temperature for 5.5 hours. After the reaction, the zinc dust was removed and the acetic acid was distilled off under reduced pressure. Ether was added to the precipitated crystals to obtain the desired product [19]. Yield: 4.42g TLC: Rf 1 = 0.18, Rf 2 = 0.67 Melting point: 210°C (decomposition) Amino acid analysis: Nle1.01(1), Glu2.05(2),
Arg0.98(1), Val/(1) 20) PF(18−34); Boc−Nle−Glu(OBzl)−
Arg(Tos)−Val−Glu(OBzl)−Trp−Len−
Arg(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu
−Gln−Asp(OBzl)−Val−His−Asn−Tyr
(Bzl-Cl 2 )-NH 2 [20] Compound [13] 8.9g (3.5mM) with 0.5 skatole
g (3.5mM), 25ml of dimethyl sulfide, 2.5ml of ethanedithiol and 25ml of TFA, and incubated at 0°C.
After stirring for 10 minutes and at room temperature for 45 minutes, the reaction solution was concentrated under reduced pressure. Add ether to the residue, take the resulting precipitate, dry it, and dissolve it in 100 ml of dry DMF.
Neutralized to PH7 with NMM. HOBt0.54 in this solution
g (4mM) and compound [19] 4.3g (4mM)
After adding 0.73ml of WSC while cooling to -15℃,
Stirred at room temperature for 2 days. After the reaction, DMF was distilled off under reduced pressure, 5% aqueous sodium bicarbonate was added to the residue, and the resulting precipitate was collected and thoroughly washed with water. The desired product [20] was obtained by dissolving this product in ethanol and adding ether to precipitate it twice. Yield: 11.12g (yield 94%) TLC: Rf 3 = 0.72 Melting point: 250℃ (decomposition) [α] 28 D -4.73゜ (C = 0.53, DMF) Amino acid analysis: Asp1.98(2), Glu3. 04(3),
Val1.69(2), Len2(2), Tyr1.07(1), Lys1.93(2),
His0.59(1), Arg1.97(2), Trp0.35(1), Nle1.07(1) 21) PF(17); Boc−Ser(Bzl)−OPAC[21] Boc−Ser(Bzl )-OH88.6g (0.3M)
Dissolve in 400ml of DMF, add 89.6g (0.45M) of phenacyl bromide, and add to this under ice cooling.
3.5 at 30℃ after dropping 62.6ml (0.45M) of Et3N
Stir for hours. Next, potassium acetate was added to this reaction solution.
22.1g (0.225M) was added and stirred at room temperature for 1 hour. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in 500 ml of ethyl acetate and washed successively with 5% aqueous sodium bicarbonate and water. After drying the ethyl acetate layer with anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The residue was left in the refrigerator to crystallize, and hexane was added to obtain the desired product [21]. Yield: 122.97g (yield 99.1%) TLC: Rf 5 = 0.82 [α] 29.5 D −11.88° (C = 1.0, DMF) Melting point: 45-47°C 22) PF (16-17); Boc-Asn- Ser(Bzl)−
OPAC [22] 50 ml of methylene chloride was added to 119.9 g (0.29 M) of compound [21], and to this was added 250 ml of TFA under ice cooling, followed by stirring at room temperature for 1 hour. After the reaction, the mixture was concentrated under reduced pressure, ether was added to the residue, and the precipitated crystals were collected and dried. The crystals were dissolved in 400 ml of dry DMF and neutralized to pH 7 with NMM. In this solution
HOBt31.35g (0.232M) and Boc−Asn−
53.88 g (0.232 M) of OH was added, and 42.46 ml (0.232 M) of WSC was added dropwise to this while cooling to -15°C, followed by stirring at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure.
The residue was dissolved in 500 ml of ethyl acetate and washed with 5% aqueous sodium bicarbonate. During the liquid separation, crystals were precipitated, so the crystals were taken and washed with water, and then with ether to obtain 41.79 g of crystals of the desired product [22]. The liquid ethyl acetate layer was concentrated under reduced pressure, and the residual oil was crystallized from ethyl acetate-ether to obtain 6.22 g of crystals of the desired product [22]. Yield: 48.01g (yield 39.2%) TLC: Rf 2 = 0.61, Rf 4 = 0.62 Melting point: 174-176°C [α] 29.5 D −5.54° (C = 1.0, DMF) Amino acid analysis: Asp1.22(1 ), Ser1.00(1) 23) PF (15-17); Boc−Leu−Asu−Ser(Bzl)
-OPAC [23] 50 ml of methylene chloride was added to 80.91 g (0.153 M) of compound [22], and then 150 ml of TFA was added under ice cooling, followed by stirring at room temperature for 1 hour. The reaction solution was concentrated under reduced pressure, ether was added to the residue, the resulting oil was separated by a decanting method, and then dissolved in 150 ml of dry DMF.
Neutralized to PH7 with NMM. This solution HOBt22.7g
(0.168M), Boc-Leu-OH・H 2 O41.9g
(0.168M) and 100ml of DMF were added, and 30.7ml of WSC (0.168M) was added dropwise while cooling to -15°C. The reaction mixture was stirred at room temperature and turned into a gel. After leaving it in an ice room for 3 days, water was removed. In addition, the resulting precipitate was collected, washed with 5% sodium bicarbonate solution and water in that order, and dried to obtain the desired product [23]. Yield: 88.52g (yield 90.3%) TLC: Rf 2 = 0.80, Rf 3 = 0.88 Melting point: 192-193°C Elemental analysis [as C 33 H 44 O 9 N 4 ] C% H% N% Calculated value 61.86 6.92 8.75 Measured value 61.81 7.05 8.56 24) PF (14−17); Boc−His(Tos)−Leu−
Asn-Ser(Bzl)-OPAC [24] To 87.55 g (0.137 M) of compound [28] was added 100 ml of methylene chloride, then 200 ml of TFA was added under ice cooling, and the mixture was stirred at room temperature for 70 minutes. The reaction solution was concentrated under reduced pressure, ether was added to the residue, the resulting precipitate was collected, dried, and dissolved in 200 ml of dry DMF.
A Boc-free solution was obtained by neutralizing to pH 7 with NMM. On the other hand, Boc-His(Tos)-OH・DCHA89.2g
(0.151M) was suspended in ethyl acetate and 1N sulfuric acid was added.
It was washed with 500 ml and the precipitated crystals were separated. The ethyl acetate layer was washed with water, dried over anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure. Dry the resulting oil
Solution dissolved in DMF150ml and HOBt20.4g
(0.151M) was added to the above-mentioned Boc-depleted solution, and -
After cooling to 15° C., 27.6 ml of WSC (0.151 M) was added dropwise, and the mixture was stirred at room temperature for 3 days. After the reaction, the solvent was distilled off under reduced pressure, the residue was added to water, and the resulting precipitate was collected, washed with 5% sodium bicarbonate solution and water in that order, and dried to obtain the target product [24]. Yield: 108.63 g (yield 85.51%) TLC: Rf 2 =0.20, 0.79 Rf = 0.55, 0.87 A product was obtained in which Tos was partially eliminated. Melting point; 154-156℃ [α] 29.5 D −18.58゜ (C=1.0, DMF) 25) PF (13-17); Boc−Lys(Z−Cl)−His−
Leu-Asn-Ser(Bzl)-OPAC [25] Compound [24] 107.96 g (0.1161 M) was added with 100 ml of methylene chloride, and then 200 ml of TFA was added under ice-cooling, followed by stirring at room temperature for 70 minutes. The reaction solution was concentrated under reduced pressure, ether was added to the residue, the resulting precipitate was collected, dried, dissolved in 200 ml of dry DMF, and diluted with NMM.
The solution was neutralized to pH 7 to obtain a Boc-free solution. On the other hand, Boc-Lys(Z-Cl)-OH・TBA62.46g
(0.128M) was suspended in 600 ml of ethyl acetate, washed successively with 1N hydrochloric acid and water, and the ethyl acetate layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. A solution of the obtained oil and 17.30 g (0.128 M) of HOBt dissolved in 100 ml of dry DMF was added to the above-mentioned Boc-removed solution, and 24.42 ml (0.128 M) of WSC was added dropwise to this while cooling to -15°C, followed by cooling to room temperature. The mixture was stirred overnight. After the reaction, the solvent was distilled off under reduced pressure, the residue was added to 3% aqueous sodium bicarbonate solution, and the precipitated crystals were thoroughly washed with water and then dried. This result was dissolved in methanol, and ether was added to precipitate it. The obtained precipitate was suspended in ethyl acetate,
The desired product [25] was obtained by repeating the steps three times. Yield: 114.42g (yield 91.8%) TLC: Rf 2 = 0.34, Rf 3 = 0.68 Melting point: 200-202°C [α] 28 D −26.94° (C = 1.0, DMF) 26) PF (13-17) ;Boc−Lys(Z−Cl)−His−
Leu-Asn-Ser(Bzl)-OH [26] Compound [25] 86.0g (80mM) was dissolved in 500ml of acetic acid, 150g of zinc powder was added thereto, stirred at room temperature for 5 hours, and the reaction solution was filtered. Zinc dust was removed. The reaction solution was concentrated under reduced pressure, ether was added to the residue, and the precipitated crystals were collected to obtain the desired product [26]. Yield: 84.70g (yield 95.2%) TLC: Rf 2 = 0.47 Melting point: 240-250℃ [α] 30 D −19.16° (C = 1.0, DMF) Elemental analysis [C 45 H 52 O 12 N 9 Cl・2CH 3 COOH・
As 2H 2 O] C% H% N% Calculated value 53.76 6.63 11.52 Measured value 52.83 6.36 11.35 Amino acid analysis; Asp1.01(1), Ser0.83(1), Leu/
(1), Lys0.93(1), His0.97(1) 27) PF(13−34); Boc−Lys(Z−Cl)−His−
Leu−Asn−Ser(Bzl)−Nle−Glu(OBzl)−
Arg(Tos)−Val−Glu(OBzl)−TrP−Leu−
Arg(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu
−Gln−Asp(OBzl)−Val−His−Asn−Tyr
(Bzl-Cl 2 )-NH 2 [27] Compound [20] 10.77g (3.2mM) with skatole
Add 0.46g (3.2mM), 25ml dimethyl sulfide, 2.5ml ethanedithiol and 25ml TFA,
After stirring at °C for 10 minutes and at room temperature for 60 minutes, the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected, dried, dissolved in 100 ml of dry DMF, and neutralized to pH 7 with NMM. Then this
HOBt0.51g (3.8mM) and compound [26]4.23
g (3.8mM) and cooled to -15°C with 0.70ml of WSC.
was added, and the mixture was stirred at room temperature overnight. After the reaction, DMF was distilled off under reduced pressure, water was added to the residue, and the resulting precipitate was collected, washed with water, and dried to obtain the target product [27]. Yield: 13.60g (yield 100%) Melting point: 138-160.5℃ [α] 28 D -19.6゜ (C=0.56, DMF) Amino acid analysis: Asp2.96(3), Ser0.62(1),
Glu3.02(3), Val1.72(2), Leu3(3), Tyr1.06(1),
Lys3.01(3), His1.43(2), Arg1.98(2), Trp0.60(1),
Nle1.06(1), 28) PF (11−12); Boc−Leu−Gly−OBzl [28] Dry 4.99 g (20 mM) of Boc−Leu−OH・H 2 O
It was dissolved in 30 ml of THF, 50 ml of dry benzene was added thereto, and the solvent was distilled off by cofluorination. The obtained oil was dissolved in 70 ml of dry THF, and H-Gly-
OBzl・TosOH (20mM) and HOBt2.7g
Add WSC5 (20mM) and then cool to -5°C.
ml and then stirred at room temperature overnight. After the reaction, the solvent was distilled off under reduced pressure, the residue was dissolved in 100 ml of ethyl acetate, and then dissolved twice with 1N hydrochloric acid and twice with 5% aqueous sodium bicarbonate.
Washed twice with water. The ethyl acetate layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure to obtain the desired product [28] as an oil. 29) PF (10−12); Boc−Asn−Leu−Gly−
OBzl [29] Add the oil obtained above [28] to -15℃ while cooling.
Add 40 ml of 4.39N hydrogen chloride/dioxane solution,
After stirring for a minute, the mixture was concentrated under reduced pressure. Add ether to the residue, remove the resulting precipitate, and dry.
Dissolved in 30ml of DMF. This was cooled to -5℃.
Add Et 3 N to adjust pH to 7, then add 0.3 g of HOBt
(2.2mM) and Boc-Asn-ONP7.77g
(22mM) was added and stirred at room temperature for 3 days. Add water to the reaction solution, and collect the precipitate in chloroform.
Extracted with 200ml. Add 1N hydrochloric acid to the chloroform layer, 5
After washing with % sodium bicarbonate solution and water in that order, and drying with anhydrous sodium sulfate,
The solvent was distilled off under reduced pressure, and the residue was crystallized from ethyl acetate-hexane to obtain the desired product [29]. Yield: 8.0g (yield 73.8%) Melting point: 152-156°C [α] 24 D -36.1° (C = 1.0, DMF) 30) PF (9-12); Boc-His-Asn-Leu-
Gly-OBzl [30] To 7.36 g (15.5 mM) of compound [29], 5 ml of methylene chloride was added, and then 32 ml of TFA was added under ice-cooling, followed by stirring at room temperature for 60 minutes. The reaction solution was concentrated under reduced pressure, ether was added to the residue, the precipitate was collected, dried, and dissolved in 40 ml of dry DMF.
The pH was adjusted to 7 with NMM to obtain a Boc-free solution. On the other hand, Boc-His(Tos)-OH・DCHA10.99g
(18.6mM) in 150ml of ethyl acetate and 90ml of 0.5N sulfuric acid
The ethyl acetate layer was washed three times with water, dried over anhydrous sodium sulfate, and then the ethyl acetate was distilled off under reduced pressure to obtain an oil. This oily substance and HOBt2.5g
(18.6mM) was dissolved in 60ml of dry DMF, and the solution was added to the above-mentioned Boc-removed solution. Then, 3.4ml (18.6mM) of WSC was added while cooling to -15°C, and the mixture was stirred at room temperature overnight. After the reaction, the solvent was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate, washed three times with 5% aqueous sodium bicarbonate and twice with water, dried over anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure. Ether was added to the residue and the precipitated crystals were collected. This crystal has some Tos removed from His, but in order to remove it completely, we need to remove this crystal.
Dissolve in 100ml of DMF, add 7.05g of HOBt to it,
Stirred at room temperature for 3 days. After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate, washed twice with 5% sodium bicarbonate water and then with water, dried over anhydrous sodium sulfate, and then the solvent was distilled off under reduced pressure. Ether was added to the precipitated crystals to obtain the desired product [30]. Yield: 7.32g (yield 74.8%) TLC; Rf 2 = 0.1 31) PF (8-12); Boc-Nle-His-Asn-
Leu-Gly-OBzl [31] To 7.32 g (11.6 mM) of compound [30], 5 ml of methylene chloride was added, and then 30 ml of TFA was added under ice-cooling, followed by stirring at room temperature for 40 minutes. The reaction solution was concentrated under reduced pressure, ether was added to the residue, the precipitate was collected, dried, and dissolved in 40 ml of dry DMF.
The pH was adjusted to 7 with NMM. This includes HOBt1.9g
(13.92mM) and Boc-Hle-OH3.23g
Add a solution of (13.92mM) in dry DMF,
After adding 2.5 ml of WSC (13.92 mM) while cooling to -15°C, the mixture was stirred at room temperature overnight. After the reaction, the solvent was distilled off under reduced pressure, water was added to the residue, the precipitate was collected and diluted twice with 5% sodium bicarbonate solution, twice with 1N hydrochloric acid, and three times with water.
The product was washed several times and dried to obtain the desired product [31]. Yield: 3.70 g (yield 42.9%) TLC; Rf 2 = 0.20 32) PF (8-12); Boc-Nle-His-Asn-
Leu-Gly-OH [32] Compound [31] 2.8g (3.8mM) in 100% ethanol
ml, 300 mg of 10% Pd/C was added thereto, and hydrogen gas was passed through it at room temperature for 3 hours. Insoluble matter precipitated in the reaction solution, so after filtering and washing with DMF,
The liquid was concentrated under reduced pressure. Add ethanol-ether to the residue to remove the precipitate and dry it to obtain the desired product [32]
I got it. Yield: 1.76g (yield 71.1%) Melting point: 112.5℃ TLC; Rf 2 = 0.05 Amino acid analysis: Asp0.96(1), Gly0.98(1), Leu/
(1), His0.95(1), Nle0.94(1) 33) PF(8-34); Boc−Nle−His−Asn−
Leu−Gly−Lys(Z−Cl)−His−Leu−Asn−
Ser(Bzl)−Nle−Glu(OBzl)−Arg(Tos)−
Val−Glu(OBzl)−TrP−Leu−−Arg(Tos)−
Lys(Z−Cl)−Lys(Z−Cl)−Leu−Gln−AsP
(OBzl)−Val−His−Asn−Tyr(Bzl−Cl 2 )−
NH 2 [33] Compound [27] 10.60g (2.5mM) of skatole
Add 0.33g (2.5mM), 25ml dimethyl sulfide, 2.5ml ethanedithiol and 25ml TFA,
After stirring at °C for 10 minutes and at room temperature for 50 minutes, the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected, dried, and then dissolved in 100 ml of dry DMF, and the pH was adjusted to 7 by adding NMM under ice cooling. To this solution were added 0.36 g (2.7 mM) of HOBt and 1.76 g (2.7 mM) of compound [32], and after adding 0.5 ml of WSC while cooling to -15°C, the mixture was stirred at room temperature overnight. The precipitate was collected, washed with water, dried, and reprecipitated from ethanol-ether to obtain the desired product [33]. Yield: 10.94g (yield 91.7%) Melting point: 140.5-162℃ [α] 28 D -1.94゜ (C=0.52, DMF) Amino acid analysis: Asp3.87(4), Ser0.76(1),
Glu3.34(3), Gly0.77(1), Val1.84(2), Leu4(4),
Tyr1.04(1), Lys3.28(3), His2.37(3), Ars2.14(2),
Trp0.73(1), Nle2.07(2) 34)) PF(7); Boc−Leu−OPAC[34]Boc−
15.0g (60mM) of Leu-OH・H 2 O and 17.9g (90mM) of phenacyl bromide were dissolved in 100ml of DMF, and 12.5ml (90mM) of Et 3 N was added dropwise to this under ice cooling, followed by stirring at 30°C for 2 hours. did. Then, add 4.42g (45mM) of potassium acetate and stir at room temperature for 45mM.
After stirring for a minute, DMF was distilled off under reduced pressure. Dissolve the residue in ethyl acetate, add 5% sodium bicarbonate solution twice,
After washing twice with water and drying the ethyl acetate layer over anhydrous sodium sulfate, the solvent was distilled off under reduced pressure. The residue was left in an ice chamber and the precipitated crystals were dried to obtain the desired product [34]. Yield: 21.23g (yield 100%) TLC; Rf 1 = 0.89 35) PF (6-7); Boc-Gln-Leu-OPAC
(35) Add 20ml of methylene chloride to 20.96g (60mM) of compound [34], then add 80ml of TFA under ice cooling,
After stirring at room temperature for 40 minutes, the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected; after drying, it was dissolved in 70 ml of dry DMF, and the pH was adjusted to 7 by adding NMM under ice cooling. In this solution
HOBt8.1g (60mM) and Boc-Gln-
Add a solution of 14.78g (60mM) of OH in 90ml of dry DMF, and add 10.9ml of WSC while cooling to -15℃.
(60mM) was added dropwise, and the mixture was stirred at room temperature overnight.
After the reaction, DMF was distilled off under reduced pressure, and the residue was dissolved in ethyl acetate, then dissolved twice with 5% sodium bicarbonate solution and twice with 1N hydrochloric acid.
Washed twice with water and three times with water. The ethyl acetate layer was dried over anhydrous sodium sulfate, and the solvent was distilled off under reduced pressure. The precipitated crystals were collected by adding hexane and dried to obtain the desired product (35). Yield: 17.25 g (yield 60.2%) ) TLC; Rf 1 = 0.38 36) PF (5-7); Boc−Ile−Gln−Leu−
OPAC [36] Add 10 ml of methylene chloride to 17.19 g (36 mM) of compound [35], then add 70 ml of TFA under ice cooling,
After stirring at room temperature for 60 minutes, the reaction solution was concentrated under reduced pressure. After drying the residue under reduced pressure, it was dissolved in 130 ml of dry DMF, and the pH was adjusted to 7 with NMM under ice cooling. In this solution
HOBt5.3g (39.6mM) and Boc-Ile-OH・
Add a solution of 9.5g (39.6mM) of 1/2 H 2 O in 70ml of dry DMF, and add 7.2ml of WSC while cooling to -15℃.
(39.6mM) was added dropwise, and the mixture was stirred at room temperature overnight.
After the reaction, DMF was distilled off under reduced pressure, 5% aqueous sodium bicarbonate was added to the residue, and the resulting precipitate was collected, washed with 5% aqueous sodium bicarbonate, twice with 1N hydrochloric acid, and three times with water in that order, and dried. did. This precipitate was reprecipitated from ethanol-ether to obtain the desired product [36]. Yield: 16.35g (yield 76.9%) TLC; Rf 1 = 0.41, Rf 2 = 0.68 37) PF (4-7); Boc-Glu(OBzl)-Ile-Gln
-Leu-OPAC [37] 16.24g (27.5mM) of compound [36] was added to 10ml of methylene chloride, and then 70ml of TFA was added under ice-cooling.
Next, 70 ml of TFA was added under ice-cooling, and after stirring at room temperature for 60 minutes, the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was collected, dried, and dissolved in 100 ml of dry DMF. Then, under ice cooling, NMM was added to adjust the pH to 7. 4.09g of HOBt in this solution
(30.25mM) and Boc-Glu(OBzl)-OH10.2g
(30.25mM) dissolved in 50ml of dry DMF was added, and 5.5ml of WSC was added dropwise while cooling to -15℃.
Stir overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, and 5% aqueous sodium bicarbonate was added to the residue to remove the resulting precipitate.
Washed and dried in sequence. The desired product [37] was obtained by reprecipitation from ethanol-ether. Yield: 21.68g (yield 97.1%) TLC; Rf = 0.52 38) PF (3-7); Boc-Ser(Bzl)-Glu
(OBzl)-Ile-Gln-Leu-OPAC [38] Add 10 ml of methylene chloride to 21.46 g (26.5 mM) of compound [37], then add 90 ml of TFA under ice cooling,
After stirring at room temperature for 1 hour, the reaction solution was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was taken, dried, and then dissolved in 150 ml of dry DMF.NMM was then added under ice cooling to adjust the pH to 7. Add 3.9g (29.15mM) of HOBt and Boc-Ser to this solution.
(Bzl)-OH 8.6g (29.15mM) dried DMF 50ml
Add the dissolved solution to WSC5.3 under cooling to -15℃.
ml (29.15mM) and stirred overnight at room temperature. After the reaction, DMF was distilled off under reduced pressure, 5% aqueous sodium bicarbonate was added to the residue, and the precipitate was collected. This was washed twice with 5% sodium bicarbonate solution, 1N hydrochloric acid, and four times with water, and then suspended and taken up in ether to obtain the desired product [38]. Yield: 24.8g (yield 94.7%) TLC; Rf 1 = 0.53 39) PF (2-7); Boc-Val-Ser(Bzl)-Glu
(OBzl)-Ile-Gln-Leu-OPAC [39] To 24.68 g (25 mM) of compound [38] was added 20 ml of methylene chloride, then 100 ml of ice-cold TFA, and the mixture was stirred at room temperature for 50 minutes. The reaction solution was concentrated under reduced pressure, ether was added to the residue, the resulting precipitate was taken, dried, and dissolved in 120 ml of dry DMF, and then NMM was added under ice cooling to adjust the pH to 7. Add 4.05g of HOBt (30mM) and Boc-Val- to this solution.
Add a solution of 6.5g (30mM) of OH dissolved in 80ml of dry DMF, and add 5.5ml (30mM) of WSC while cooling to -15℃.
was added dropwise, and the mixture was stirred at room temperature overnight. A precipitate was deposited in the reaction solution, so it was collected by adding water, washed twice with 5% sodium bicarbonate, twice with 1N hydrochloric acid, and four times with water, and then suspended in ether and taken. Obtained object [39]. Yield: 26.32g (yield 96.8%) TLC; Rf 1 = 0.49 40) PF (1-7); Boc-Ser (Bzl)-Val-Ser
(Bzl)−Glu(OBzl)−Ile−Gln−Leu−OPAC
[40] 20 ml of methylene chloride was added to 26.07 g (24 mM) of compound [39], and then 100 ml of TFA was added under ice cooling, followed by stirring at room temperature for 40 minutes. The reaction solution was concentrated under reduced pressure, ether was added to the residue, the resulting precipitate was collected, dried, and dissolved in 100 ml of dry DMF, and then NMM was added under ice cooling to adjust the pH to 7. Add 3.9g (28.8mM) of HOBt and Boc-Ser to this solution.
Add a solution of 8.5g (28.8mM) of (Bzl)-OH in 50ml of dry DMF, and cool to -15°C with 5.3ml of WSC.
(28.8mM) and then stirred at room temperature overnight.
A precipitate was deposited in the reaction solution, so water was added to remove it, and the precipitate was washed in the order of 5% sodium bicarbonate solution, 1N hydrochloric acid, and water.
The desired product [40] was obtained by performing the steps of suspending and removing in ether twice. Yield: 28.0g (yield 92.3%) TLC; Rf 1 = 0.53 41) PF (1-7); Boc-Ser (Bzl)-Val-Ser
(Bzl)-Glu(OBzl)-Ile-Gln-Leu-OH [41] Compound [40] 12.6g (10mM) was dissolved in 300ml of acetic acid, 15g of zinc powder was added thereto, and the mixture was stirred at 50°C for 4 hours. , zinc powder was separated. Acetic acid was distilled off under reduced pressure, ether was added to the residue, and the precipitated crystals were collected and washed to obtain the desired product [41]. Yield: 11.15g (yield 97.4%) Melting point: 260℃ (decomposition) TLC: Rf 1 = 0.14, Rf 2 = 0.64 Amino acid analysis: Ser1.81(2), Glu2.02(2),
Val0.95(1), Leu1(1), Ile0.92(1) 42) Protection-[Nle 8 , Nle 18 , Tyr 34 ]-h-PTH
(1-34)NH 2 ; Boc−Ser(Bzl)−Val−Ser
(Bzl)−Glu(OBzl)−Ile−Gln−Leu−Nls−
His−Asn−Leu−Gly−Lys(Z−Cl)−His−
Leu−Asn−Ser(Bzl)−Nle−Glu(OBzl)−
Arg(Tos)−Val−Glu(OBzl)−Trp−Leu−
Arg(Tos)−Lys(Z−Cl)−Lys(Z−Cl)−Leu
−Gln−Asp(OBzl)−Val−His−Asn−Tyr
(Bzl) -Cl2 ) -NH2 [42] Compound [33] 10.86g (2.28mM), skatole 0.30g (2.28mM), dimethyl sulfide 25 under ice cooling
ml, ethanedithiol 2.5 ml and TFA 25 ml, and after stirring at room temperature for 60 minutes, the mixture was concentrated under reduced pressure. Ether was added to the residue, and the resulting precipitate was taken and dried, then dissolved in a mixture of 100 ml of dry DMF and 10 ml of DMSO, and the pH was adjusted to 7 by adding NMM under ice cooling. To this solution were added 0.37g (2.74mM) of HOBt and 3.14g (2.74mM) of compound [41], and then 0.50ml (2.74mM) of WSC was added while cooling to -15°C, followed by stirring at room temperature overnight. Add water to the reaction solution,
The resulting precipitate was collected, thoroughly washed with water, and then washed with ethanol-ether to obtain the desired product [42]. Yield: 12.87g (yield 97.3%) Melting point: 139.5-175℃ [α] 28 D -1.97゜ (C=0.51, DMF) Amino acid analysis: Asp3.72(4), Ser2.76(3),
Glu5.58(5), Gly0.69(1), Val2.86(3), Ile1.11(1),
Leu5(5), Tyr0.99(1), Lys2.87(3), His2.19(3),
Arg2.06(2), Trp0.65(1), Nle1.96(2) 43) [Nle 8 , Nle 18 , Tyr 34 ] −h−PTH(1−
34) 3.5 ml of anisole, 0.35 ml of ethanedithiol, 3.5 ml of dimethyl sulfide and 35 ml of anhydrous HF were added to 2.9 g (0.5 mM) of NH 2 compound [42] while cooling at 0° C., and the mixture was stirred for 60 minutes. After the reaction, HF was distilled off under reduced pressure, ether was added to the residue, the resulting precipitate was collected, and then dissolved in 0.1N acetic acid. Apply this solution to a Dowex x 1 (acetate type) column (3.5 x 12
cm), and only the ninhydrin-positive fraction was collected and lyophilized to obtain 1.87 g of crude product.
Dissolve this in 50ml of 0.1N acetic acid, charge it to a CM-cellulose column (2 x 33cm), and apply a linear concentration gradient of 0.05M ammonium acetate (PH5.1) to 0.4M ammonium acetate (PH6.0)1. Elution was performed. Each fraction is divided into 9.0ml,
74 with a spot near Rf 6 = 0.30 due to TLC
~84th fraction was collected and freeze-dried. Dissolve this in as little amount of 0.1N hydrochloric acid as possible, and apply this solution to a Sephadex G-25 column (3 x 115
cm) and eluted with 0.1N acetic acid. The absorbance of each fraction was measured at UV 280 nm, and only the fractions with one large peak were collected and freeze-dried [Nle 8 , Nle 18 , Tyr 34 ].
-h-PTH(1-34) NH2 was obtained. Yield: 140 mg TLC; Rf 6 = 0.30 Amino acid analysis (6N containing 3% thioglycolic acid)
Hydrolyzed with hydrochloric acid); Asp3.98(4), Ser2.10(3),
Glu4.93(5), Gly0.97(1), Val2.66(3), Ile0.87(1),
Leu5.00(5), Tyr1.11(1), Lys3.26(3), His2.30(3),
Arg2.03(2), Trp0.62(1), Nle2.22(2) High performance liquid chromatography; Column; Nucleosil 5 C 18 (4nmID×150mm) Buffer; 0.1% acetic acid-acetonitrile containing 0.1M phosphoric acid (The ratio of acetonitrile is
Flow rate: 1 ml/min Detection: 225 nm Measurement result: Peak detected only at 19.07 min.

Claims (1)

【特許請求の範囲】 1 式 H−Ser−Val−Ser−Glu−Ile−Gln−Leu−
Nle−His−Asn−Leu−Gly−Lys−His−Leu−
Asn−Ser−Nle−Glu−Arg−Val−Glu−Trp−
Leu−Arg−Lys−Lys−Leu−Gln−Asp−Val−
His−Asn−Tyr−NH2 で表されるペプチドまたはその塩。
[Claims] 1 Formula H-Ser-Val-Ser-Glu-Ile-Gln-Leu-
Nle−His−Asn−Leu−Gly−Lys−His−Leu−
Asn−Ser−Nle−Glu−Arg−Val−Glu−Trp−
Leu−Arg−Lys−Lys−Leu−Gln−Asp−Val−
A peptide represented by His-Asn-Tyr- NH2 or a salt thereof.
JP58144016A 1983-08-05 1983-08-05 (nle8,nle18,tyr34)-h-pth(1-34)nh2 Granted JPS6034996A (en)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP58144016A JPS6034996A (en) 1983-08-05 1983-08-05 (nle8,nle18,tyr34)-h-pth(1-34)nh2
FR8412303A FR2550204B1 (en) 1983-08-05 1984-08-03 PEPTIDE DERIVATIVES OF (NLE8, NLE1B, TYR34) -H-PTH
US06/637,735 US4656250A (en) 1983-08-05 1984-08-06 [Nle8, Nle18, Tyr34 or Phe34 ]-h-PTH peptide derivatives
DE3428942A DE3428942C2 (en) 1983-08-05 1984-08-06 (H-PTH) PEPTIDE DERIVATIVES

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP58144016A JPS6034996A (en) 1983-08-05 1983-08-05 (nle8,nle18,tyr34)-h-pth(1-34)nh2

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP3013849A Division JPH0592995A (en) 1991-01-10 1991-01-10 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2

Publications (2)

Publication Number Publication Date
JPS6034996A JPS6034996A (en) 1985-02-22
JPH0352479B2 true JPH0352479B2 (en) 1991-08-12

Family

ID=15352358

Family Applications (1)

Application Number Title Priority Date Filing Date
JP58144016A Granted JPS6034996A (en) 1983-08-05 1983-08-05 (nle8,nle18,tyr34)-h-pth(1-34)nh2

Country Status (1)

Country Link
JP (1) JPS6034996A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008020483A1 (en) 2006-08-18 2008-02-21 Hitachi, Ltd. Bearing device for gas turbine power generation facility and gas turbine power generation facility

Also Published As

Publication number Publication date
JPS6034996A (en) 1985-02-22

Similar Documents

Publication Publication Date Title
US4656250A (en) [Nle8, Nle18, Tyr34 or Phe34 ]-h-PTH peptide derivatives
CA2052375C (en) Parathyroid hormone derivatives
JP2726647B2 (en) Cyclic peptides and their uses
CA1065856A (en) Derivatives of salmon calcitonin
JPH0753752B2 (en) Enzyme resistant immunomodulatory peptide
IE44426B1 (en) Polypeptide
JPH0684400B2 (en) Novel growth hormone-free peptide
EP1179537B1 (en) Solid phase peptide synthesis method
JPS5896052A (en) Preparation of highly active h-pth (1-34) amide
JPS6220200B2 (en)
JPH0745517B2 (en) Peptides and methods for producing cyclic peptides
JPH0352479B2 (en)
JPH051798B2 (en)
US3873510A (en) Peptides of ACTH activity containing {60 -aminooxy carboxylic acid on the N-terminal moiety, and a process for the preparation thereof
FUJII et al. Studies on Peptides. CLX.: Synthesis of a 33-Residue Peptide Corresponding to the Entire Amino Acid Sequence of Human Cholecystokinin (hCCK-33)
FUJII et al. Studies on Peptides. CLVI. Synthesis of Second Human Calcitonin Gene-Related Peptide (β-hCGRP) by Application of a New Disulfide-Bonding Reaction with Thallium (III) Trifluoroacetate
JPH0687891A (en) Peptide compound having bradykinin antagonist activity
JPH047360B2 (en)
JPH0592995A (en) 125 i-labeled radioactive substance of (nle8,nle18,tyr34)-h-pth(1-34)nh2
JPS6342639B2 (en)
WO1991016341A1 (en) Peptide derivatives
JPS6267099A (en) (nleb, 21,)-r-pth(1-34) peptide derivative
FUJII et al. Studies on Peptides. CLXII.: Synthesis of Chicken Calcitonin-Gene-Related Peptide (cCGRP) by Application of Sulfoxide-Directed Disulfide-Bond-Forming Reaction
Fletcher et al. Amino-acids and peptides. Part XXXVII. Trifluoroacetylation during the coupling of t-butoxycarbonylamino-acids with peptide esters in the presence of trifluoroacetate anion
JPS6157600A (en) (nie8, nie21, tyr34)-r-pth(1-34)nh2)